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ABSTRACT 
 
 Pathogenic bacteria improve their fitness, pathogenicity and virulence by acquisition of 
mobile genetic elements (MGE). These MGE carry genes for antibiotic resistance, 
toxins, virulence factors, etc. Staphylococcus epidermidis is a leading cause of 
nosocomial infections in patients with a compromised immune system and an implanted 
medical device. It has an open pan-genome with 20% variable genes. In my studies of S. 
epidermidis clinical isolates, I have discovered two genes that code for surface proteins, 
S. epidermidis surface protein J (SesJ) and Plasmin sensitive protein (Pls). These genes 
are present in a Staphylococcal Cassette Chromosome containing methicillin resistance 
gene (SCCmec). Further analysis has shown that SesJ contains structural features 
characteristic of Microbial surface components recognizing adhesive matrix molecules 
(MSCRAMMs), known major virulence factors of Gram-positive pathogenic bacteria. 
SesJ also contains a N-terminal repeat (NTR) region that has not been previously 
observed in MSCRAMMs. SesJ structural homologs were identified in three other 
coagulase negative staphylococci composing a new MSCRAMM NTR-containing 
subfamily.  
 
171 clinical isolates were retrospectively collected from MD Anderson, Houston, and 
examined for the presence and location of the sesJ and the pls genes. Work presented in 
this dissertation show that the sesJ gene is prevalent in ST2, ST5 and ST 210 isolates, 
while the pls gene is present only in ST2. ST2 and ST5 isolates accounted for over 50% 
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of the total isolates. Genetic location identification showed that sesJ is present in 
SCCmec Type IV and SCCmec Type VII. Different isoforms of SesJ were also observed 
in CC2 and CC5 isolates. Pls has been previously reported in S. aureus, where it is 
present in the SCCmec Type I. However in this study, the pls gene was discovered in S. 
epidermidis SCCmec Type IV. Additionally, the frequency of the sesJ gene has 
increased three folds in past three years. In summary, I discovered two novel surface 
proteins present in SCCmec. In the future, we will corroborate the presence of these 
genes with clinical outcome in patients and determine the role of SesJ in the S. 
epidermidis pathogenicity.  
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NOMENCLATURE 
 
Aae Autolysin/adhesin of S.epidermidis 
Aap Accumulation associated protein 
ACME Arginine catabolic mobile element 
AltE Autolysin E 
Bbp Bonesialo binding protein 
CHIP Chemotaxis inhibitory protein 
CLABSI Central line associated bloodstream infection 
ClfA Clumping factor A 
ClfB Clumping factor B 
Cna Collagen adhesion 
CoNS Coagulase negative Staphylococcus 
CWA  Cell wall anchored  
DLL Dock lock and latch 
DNA Deoxyribonucleic acid 
Ebp Elastin binding protein 
Embp Extracellular matrix binding protein 
Esp S. epidermidis serine protease 
FBR Foreign body related 
FBR-BSI Foreign body related-bloodstream infection 
FBRI Foreign body related infection 
 ix 
 
 
FnBP Fibronectin binding protein 
GupSE Glutamyl endopeptidase 
HGT Horizontal gene transfer 
ICE Integrated conjugative element 
IgG Immunoglobulin G 
MGE Mobile genetic element 
MLS B Macrolide, lincosamide and streptogramin B 
MSCRAMM Microbial surface components recognizing adhesive matrix                     
                                    Molecules 
PBP Penicillin binding protein 
PBP2’ Penicillin binding proteins 2’ 
PGA Poly-γ-DL-glutamic acid 
PIA Polysaccharide intercellular adhesion 
Pls Plasmin sensitive protein 
PSM Phenol soluble modulin 
RNA Ribonucleic acid 
SasX Staphylococcus aureus surface protein X 
SCC Staphylococcal cassette chromosome 
SCIN Staphylococcal inhibitor of complement 
SdrC Serine aspartate dipeptide repeat protein C 
SdrD Serine aspartate dipeptide repeat protein D 
SdrE Serine aspartate dipeptide repeat protein E 
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SdrF Serine aspartate dipeptide repeat protein F 
SdrG Serine aspartate dipeptide repeat protein G 
SEC3                           Staphylococcal enterotoxin C3  
SEIL                           Staphylococcal enterotoxin-like toxin L 
SepA Staphylococcal efflux pump A 
SePI Staphylococcus epidermidis pathogenicity island 
SesC Staphylococcus epidermidis surface protein C 
SesI Staphylococcus epidermidis surface protein I 
SesJ Staphylococcus epidermidis surface protein J 
SspA Staphylococcal serine protease A 
ST Sequence type 
tRNA Transfer ribonucleic acid 
TSST Toxic shock syndrome toxin 
 
 
 xi 
 
 
TABLE OF CONTENTS 
 
                                                                                                                                       Page                                                                                                                                                               
ABSTRACT  ....................................................................................................................... ii 
DEDICATION  .................................................................................................................. iv   
ACKNOWLEDGEMENTS  ............................................................................................... v 
CONTRIBUTORS AND FUNDING SOURCES  ............................................................ vii 
NOMENCLATURE  ........................................................................................................ viii 
TABLE OF CONTENTS  .................................................................................................. xi 
LIST OF FIGURES  ......................................................................................................... xiii 
LIST OF TABLES  .......................................................................................................... xiv 
CHAPTER I INTRODUCTION AND LITERATURE REVIEW  .................................... 1 
            Clinical relevance of the dissertation  ..................................................................... 1 
            S. epidermidis and other CoNS  .............................................................................. 2 
            MSCRAMMs  ....................................................................................................... 11 
            Mobile genetic elements  ....................................................................................... 21 
            Horizontal gene transfer  ....................................................................................... 37 
            CoNS as a reservoir of antibiotic resistance  ......................................................... 39 
CHAPTER II A NOVEL MSCRAMM SUBFAMILY IN COAGULASE NEGATIVE 
STAPHYLOCOCCAL SPECIES  .................................................................................... 41 
            Introduction  .......................................................................................................... 42 
            Materials and methods  ......................................................................................... 44 
            Results  .................................................................................................................. 47 
            Discussion  ............................................................................................................ 62 
CHAPTER III SESJ AND PLS ARE PRESENT IN A COMPOSITE SCCmec  
ELEMENT  ....................................................................................................................... 68 
 
 
 xii 
 
 
            Introduction  .......................................................................................................... 68 
            Materials and methods  ......................................................................................... 71 
            Results  .................................................................................................................. 80 
            Discussion  ............................................................................................................ 90 
CHAPTER IV CONCLUSIONS  ..................................................................................... 95 
REFERENCES  ............................................................................................................... 107 
 xiii 
 
 
LIST OF FIGURES                 
                                                                                                                                            
                                                                                                                                       Page 
Figure 1. Schematic representation of biofilm formation  .................................................. 6 
Figure 2. Cartoon representation of previously characterized subfamilies of  
              MSCRAMM  ....................................................................................................... 13           
Figure 3. Dock, lock and latch model  .............................................................................. 16 
Figure 4. Collagen hug model  .......................................................................................... 17 
Figure 5. Structural organization of SCCmec  .................................................................. 27 
Figure 6. Schematic representation of SCCmec types  ..................................................... 30 
Figure 7. Synthesis of peptidoglycan for cell wall formation  .......................................... 32 
Figure 8. The mec operon and its expression in absence/presence of methicillin ............ 34 
Figure 9. Integration and excision of SCCmec  ................................................................ 36 
Figure 10. Mechanisms of horizontal gene transfer in prokaryotes  ................................. 38 
Figure 11. Comparison of SesJ with other structurally related proteins  .......................... 49 
Figure 12. Detection of SesJ expression on the surface of S. epidermidis by flow        
                cytometry  .......................................................................................................... 56 
Figure 13. SesJ structural homologs in other CoNS species  ............................................ 59 
Figure 14. Conserved motif in the NTRs of SesJ structural homologs  ............................ 63 
Figure 15. The sesJ gene is located in composite SCCmec element  ................................ 86 
Figure 16. Sequence comparison of SesJ A-region from different STs  ........................... 87 
Figure 17. Frequency of the sesJ+ S. epidermidis isolates is increasing  .......................... 91 
 
 xiv 
 
 
LIST OF TABLES 
  
                                                                                                                                       Page 
 
Table 1. Virulence factors of S. epidermidis  .................................................................... 10 
 
Table 2. Functions of unknown MSCRAMMs  ................................................................ 19 
 
Table 3. The ccr and mec gene complex present in SCCmec types  ................................. 29 
 
Table 4. Conserved motifs in the A-region of SesJ structural homologs  ......................... 51 
Table 5. Summary of NTRs of SesJ structural homologs  ................................................ 53 
Table 6. Presence of virulence genes in the isolates  ........................................................ 74 
Table 7. Presence of the sesJ and the pls gene in different ST  ........................................ 81 
Table 8. Presence of the sesJ and pls gene in MRSE and MSSE isolates  ....................... 83 
Table 9. SesJ isoforms are present in different clonal complexes .................................... 89 
 
 
 
 
 
 
 
 
 
 
 
1 
 
CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
Clinical relevance of the dissertation  
 
Staphylococcal species are the leading cause of nosocomial infections in the USA. 
Methicillin resistant Staphylococcus aureus alone causes about 80,000 severe invasive 
infections per year and 11,285 of these infections lead to death in the U.S. alone [1]. 
Coagulase negative staphylococci (CoNS), especially S. epidermidis often causes 
infections in immunosuppressed/immunocompromised patients and patients with 
inserted/implanted foreign material. S. epidermidis is the leading causative agent of 
inserted/implanted foreign body-related infections (FBRIs), which usually result in 
foreign body – related bloodstream infections (FBR-BSIs). Patients with FBR-BSIs 
characteristically have longer hospital/ICU stays as well as higher mortality rates and 
associated costs compared to uninfected patients. 
 
Staphylococci are notorious for developing resistance against antibiotics.  Increasing 
antibiotic resistance amongst staphylococci makes it extremely challenging to treat these 
infections.  Therefore, infections caused by staphylococci, especially S. epidermidis 
represent a serious burden on the health care system and hence it is important to 
characterize the virulence factors that are involved in these types of infections. The 
genes responsible for antibiotic resistance and novel virulence factors are acquired 
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through horizontal gene transfer (HGT). S. epidermidis is evolving through the addition 
of new virulence factors and antibiotic resistance genes. Increased knowledge of the 
mechanism of these novel virulence factors and their impact on establishing infections is 
the key to developing drugs to treat S. epidermidis infections.  
 
S. epidermidis and other CoNS 
 
General characteristics  
Staphylococci are gram-positive bacteria, which under the microscope form round, 
grape-like clusters. There are 47 species and 23 subspecies under the genus 
Staphylococcus. The genus is divided mostly into two groups based on the presence of 
coagulase, a major virulence factor that causes clotting of blood: coagulase positive 
staphylococci (S. aureus, S. pseudintermedius and few others) and coagulase negative 
staphylococci (S. epidermidis, S. haemolyticus etc.). In addition, some staphylococci 
species are coagulase variable e.g. S. schleiferi includes both a coagulase positive 
subspecies (S. schleiferi subsp. coagulans) and a coagulase negative subspecies (S. 
schleiferi subsp. scheiferi) [2].  
 
CoNS is a part of the commensal skin flora. S. epidermidis is the most frequently 
isolated staphylococcal species from humans, particularly from moist areas such as 
axillae, and anterior nares, toe webs and perineal areas [3, 4]. S. capitis is present around 
the forehead sebaceous glands [5]. S. haemolyticus colonizes axillae and pubic areas. S. 
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saprophyticus is isolated from the rectum and the genitourinary tract [4, 6]. CoNS was 
previously considered as a contaminant of blood cultures isolated from patients because 
of their ubiquitous presence on human skin. 
 
Clinical significance  
Presently, CoNS are regarded as opportunistic pathogens and are a major cause of 
nosocomial infections. S. epidermidis and S. haemolyticus are most frequently associated 
with diseases in humans compared to other CoNS. S. epidermidis is “medium” 
pathogenic staphylococci i.e. it expresses less virulent factors compared to S. aureus. 
However, S. epidermidis causes a different disease spectrum than S. aureus[2]. The 
pathogenic potential of S. epidermidis lies in its ability to colonize and infect every 
biomaterial developed to date. The most common isolates recovered from nosocomial 
central-line associated bloodstream infections (CLABSI), as recorded by National 
Healthcare Safety Network at the Centers for Disease Control and Prevention, were 
CoNS, with S. epidermidis responsible for half of these infections [7].  Studies have 
reported that patients with CLABSI had significantly longer ICU and hospital length of 
stay, higher mortality and hospital costs than uninfected patients [8, 9]. The estimated 
attributable cost per infection is $ 11,971 (2006 dollars) to $45, 814 (2012 dollars) [10, 
11]. Other FBR-blood stream infections include infections associated with prosthetic 
heart valves and vascular grafts, cardiac devices, and coronary stents [2].  
 
Other infections caused by S. epidermidis include native valve endocarditis, infections in 
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preterm infants and in very low birth infants, and bacteremia/septicemia in patients. 
CoNS is an emerging important cause of native valve endocarditis in both health care 
and community settings. In one study, data published from the International 
Collaboration on Endocarditis Prospective Cohort study involving 1635 patients from 61 
centers in 28 countries, showed that CoNS was responsible for ~8% of these cases in 
patients with no history of injection drug use. It was also reported that native valve 
endocarditis due to CoNS is associated with poor outcomes, i.e. prolonged symptom 
duration and congestive heart failure. S. epidermidis alone caused 80% of the infections 
reported in this study [12]. In addition, CoNS frequently causes late-onset sepsis in 
neonates, especially very low birth weight infants. Amongst CoNS, S. epidermidis is the 
most prevalent pathogen in neonates [13, 14]. Furthermore, blood stream infection is a 
severe complication in patients with chemotherapy-induced neutropenia. CoNS was 
responsible for 40% of infections caused in a multicenter study of 1,051 bacteremia 
episodes in 782 cancer patients [15].  
 
CoNS, other than S. epidermidis are also regarded as opportunistic pathogens.  
After S. epidermidis, amongst CoNS S. haemolyticus is the second most isolated 
pathogen from human blood cultures [16, 17]. S. haemolyticus has adapted very well to 
the hospital environment because of its genome plasticity and acquisition of antibiotic 
resistant determinants [18]. Additionally, S. saprohyticus is the second leading cause of 
urinary tract infection in young, sexually active women, after E. coli [19]. S. capitis is 
also emerging as important opportunistic pathogen in neonatal intensive care units. S. 
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capitis has been reported to cause more infections than S. epidermidis, in infants 
admitted in neonatal intensive care units [20].  
 
In conclusion, an increase in the use of indwelling or implanted foreign bodies, and an 
increase in the number of patients with impaired immune system has established CoNS 
as one of the major nosocomial pathogens.  
 
Biofilm  
Biofilm is defined as a surface attached aggregate of bacteria forming a distinct 
architecture. Biofilm consists of bacterial communities embedded in a matrix where 
bacteria have unique transcriptional responses from those growing in the planktonic 
phase [21, 22]. Bacteria in staphylococci biofilm have heterogeneous states (aerobically 
and anaerobically growing cells, dormant and dead cells) due to spatial and temporal 
responses to their surrounding environment [23, 24]. This heterogeneity of biofilms is 
responsible for enhanced tolerance to antimicrobials like antibiotics, and antibodies [23]. 
Staphylococci have established themselves as successful nosocomial pathogens because 
of their ability to form biofilm on biomaterials. The process of forming a biofilm is 
divided into three stages: attachment, accumulation and dispersion (Figure 1).  
 
The first step in biofilm formation is the attachment of the bacteria to abiotic or 
conditioned surfaces. This step is crucial for establishing infection. The expression of 
autolysin E (AtlE) and Autolysin/adhesion of S. epidermidis (Aae) changes cell surface  
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Figure 1. Schematic representation of biofilm formation. Adapted with permission 
from [25]. 
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hydrophobicity, which mediates the attachment to abiotic surface through nonspecific 
and hydrophobic interactions [26, 27].  Once inserted in a host, human serum proteins 
e.g. fibrinogen, collagen and fibronectin quickly adhere to the biomaterial [28]. Not 
surprisingly, S. epidermidis expresses surface proteins that can mediate interactions with 
human serum proteins. Serine aspartate dipeptide repeat protein G (SdrG) and F (SdrF) 
belong to microbial surface components recognizing adhesive matrix molecules 
(MSCRAMM) family of surface proteins [29]. SdrG binds to human fibrinogen and this 
interaction has been shown to play a role in colonizing biomaterial [30, 31]. On the other 
hand, SdrF binds to α1 and α2 chains of Type 1 collagen [32]. Reports show that SdrF 
binds to unmodified Dacron surfaces covering drivelines as well as collagen coated on 
cardiac assist device drivelines [33]. In addition extracellular matrix binding protein 
(Embp) binds to fibronectin and potentially contributes to the attachment phase [34, 35]. 
Two bacterial autolysins also play a role in attachment. The autolysins AltE and Aae 
release eDNA into the matrix after cell lysis [36]. Extracellular DNA (eDNA) plays a  
role in primary attachment as addition of DNase I reduced bacterial attachment to glass 
surface [37].  
 
After attachment, the next step of biofilm formation is known as accumulation, where 
intercellular adhesion molecules cause bacteria to aggregate and develop a multicellular, 
multilayered biofilm architecture [23]. Two critical factors shown to play a role in the 
accumulation phase are polysaccharide intercellular adhesion (PIA) and Accumulation 
associated protein (Aap). PIA is a homoglycan composed of β-1,6-linked 2-amino-2- 
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deoxy-2-glyucopyranol residues [38]. PIA is synthesized by the genes in the ica operon 
[39]. PIA plays a role in initial attachment, accumulation, and the architecture of the 
mature biofilm [23, 32]. Biofilm generated by PIA expressing S. epidermidis isolates 
have significant tower formation and 3D structure [23]. Although PIA is critical for 
biofilm formation, S. epidermidis isolates that lack the ica operon can still cause 
clinically significant infections.  PIA independent biofilms are protein dependent [40]. 
The Aap protein has been shown to play a significant role in PIA independent or protein 
dependent biofilms. Aap is a cell wall anchored protein on the surface of S. epidermidis 
[41]. The B domains of Aap dimerize with B domains of Aap on the neighboring cells in 
a Zn2+  dependent manner causing cells to aggregate [42]. The Aap-dependent biofilms 
show less tower formation than the PIA dependent biofilms. The biofilm associated 
protein homolog (Bhp) and embp, cell wall anchored proteins in S. epidermidis also play 
a role in biofilm accumulation phase in absence of both PIA and Aap [35, 43].   
 
The last stage of biofilm formation is known as dispersal. During dispersal, individual 
cells or sections of biofilm separate from the mature biofilm and migrate to other organs 
[44]. Phenol soluble modulin (PSM) are pro-inflammatory peptides regulated by the agr 
gene [45]. PSM-β inhibit noncovalent interactions between bacteria and the biofilm by 
acting as a surfactant and thereby promoting biofilm detachment [46]. Wang et al. 
[47]showed that in vivo PSM-β helps in dissemination of S. epidermidis from infected 
catheters to other organs. Agr, a two-component system, also regulates biofilm dispersal 
by upregulating proteases that cleave proteins involved in biofilm accumulation [48].  
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Virulence factors 
Virulence factors are defined as factors that enable replication and dissemination of 
bacteria in the host by evading host immune response. Virulence factors can be divided 
in to different categories: (i) colonizing factors – molecules that allow bacteria to 
colonize host, (ii) adhesion factors – molecules that enable bacteria to adhere to host 
cells, (iii) invasion factors – molecules that allow bacteria to invade host cells, and (iv) 
evasion factors – molecules that allow bacteria to evade host immune responses by either 
subverting responses or killing host cells. S. epidermidis has lower virulence potential 
compared to S. aureus because it lacks the toxins encoded in S. aureus [24]. Instead, S. 
epidermidis relies on immune evasion factors, which promote persistence. S. epidermidis 
evades host response through biofilm formation, production of protective exopolymers, 
and sensing of antimicrobial peptides [24, 32]. Table1 is a summary of virulence factors 
encoded by S. epidermidis and their function.  
 
Antibiotic resistance  
Antibiotic resistance is widespread amongst clinical S. epidermidis isolates. CoNS 
appear to serve as a reservoir for genes encoding virulence factors that can be transferred 
horizontally to other staphylococcal species including S. aureus. Resistance to 
methicillin, rifamycin, fluoroquinolones, gentamicin, tetracycline, chloramphenicol, 
erythromycin, clindamycin and sulfonamides has been reported in S. epidermidis. 73-
80% of S. epidermidis isolates obtained in the clinic are resistant to methicillin [49, 50]. 
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Virulence factor  Function Reference 
AltE Autolysin, binds to vitronectin [26] 
Aae Autolysin, binds to fibrinogen, 
fibronectin and vitronectin 
[27] 
SdrF Binds to collagen, initiation of 
ventricular assist device driveline 
infections 
[31, 51] 
SdrG Binds to fibrinogen, attachment to 
catheters 
[29, 30] 
 
Embp Binds to fibronectin, intercellular protein 
adhesin 
[34, 35] 
Ebp Binds to elastin [52, 53] 
Bhp Intercellular protein adhesion [43] 
PIA Intercellular polysaccharide adhesion, 
immune evasion 
[54, 55]  
 
Aap Binds to corneocytes, initial attachment 
in biofilm, intercellular protein adhesin 
[56, 57]  
Teichoic acids Component of biofilm matrix [58] 
PGA Forms outer capsule, protects from 
antimicrobial peptides and phagocytosis 
[59]  
SepA  Protease, antimicrobial peptide 
degradation 
[60] 
Antimicrobial peptide 
sensing system 
Antimicrobial peptide sensor, regulates 
antimicrobial resistance mechanism 
[61, 62] 
Phenol soluble modulin 
(PSM) α 
Cytolysin, pro-inflammatory [63, 64] 
PSM β1, PSM β2 Biofilm detachment, pro-inflammatory [47] 
PSM δ Cytolysin, pro-inflammatory [65, 66] 
PSM ε Cytolysin, pro-inflammatory [65, 66] 
δ-toxin Cytolysin, pro-inflammatory [65, 66] 
PSM-mec Cytolysin, pro-inflammatory [65, 66] 
SEC3, SEIL Enterotoxins located in pathogenicity 
island 
[67] 
Fatty acid modifying 
enzyme 
Detoxification of bactericidal fatty acids [68] 
SesC Biofilm formation [69, 70] 
Table 1. Virulence factors of S. epidermidis. 
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MSCRAMMs 
 
Cell wall-anchored (CWA) proteins of bacterial pathogens are important factors to 
establish adherence to host tissues, a critical step in the pathogenesis of microbial 
infections [28]. Bacterial CWA proteins are described as mosaic proteins composed of 
interlinked domains. These CWA proteins are grouped into families based on structural 
or functional homology [71]. Many CWA proteins of Gram-positive bacteria contain 
two linked IgG-like folded domains, which mediate ligand binding using the dock, lock 
and latch (DLL) model. These surface proteins are grouped into the Microbial surface 
components recognizing adhesive matrix molecules (MSCRAMMs) family [29, 72].  
 
All MSCRAMMs have a N-terminus signal sequence, an A-domain containing usually 
the ligand binding region, a C-terminus wall spanning region, LPXTG motif, a 
hydrophobic membrane spanning domain and a cytoplasmic tail. N-terminus signal 
sequences (~40 aa) is required for secretion through Sec-dependent pathway. The A-
domain of staphylococcal MSCRAMMs is further divided into three sub-domains: N1, 
N2 and N3. The N2 and N3 sub-domains adopt IgG-like folds and represent the principal 
ligand-binding sub region. N2N3 sub- domains of MSCRAMMs bind ligand through the 
DLL mechanism.  The cell wall spanning region is rich in either glycine and proline  
residues or serine and aspartate residues [28, 52]. MSCRAMMs are anchored to the cell 
wall through sortase enzyme, which recognizes the LPXTG motif present in surface 
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proteins. The sortase enzyme cleaves the bond between threonine and glycine residues. 
The carboxyl group of threonine is then covalently linked to the branch peptide in the 
peptidoglycan, anchoring the protein to the bacterial surface [73, 74]. Due to processing 
of the nascent peptide, the N-terminus signal sequence, the membrane spanning region 
and the cytoplasmic tail are not present in mature protein on the surface of the bacteria 
[74, 75]. 
 
Three known families of MSCRAMM  
Clumping factor-Serine aspartate dipeptide repeat (Clf-Sdr) family 
 In S. epidermidis, this sub-family of proteins contain SdrF and SdrG [76]. In S. aureus, 
ClfA, ClfB, SdrC, SdrD, SdrE, Bbp constitute Clf-Sdr sub-family [77].  Figure 2a shows 
relative positions of the N-terminus signal peptide, the A-domain (A), the B-repeat 
domains (Bn), the serine-aspartate dipeptide repeat region, the LPXTG motif and the cell 
wall/membrane- spanning region. Serine-aspartate dipeptide region, a characteristic 
feature of Clf-Sdr sub-family acts as linker to extend the A-domain away from the 
bacterial cell surface [78]. The SdrC/D/E/G/F and Bbp proteins contain B-repeats (~110 
aa) [79]. With the exception of SdrF, these proteins bind to their ligands through N2N3 
sub-domains of the A-domain [77]. In SdrF, the B-repeats instead of the A-domain bind 
to Type IV collagen [31]. The function of SdrF A-domain in unknown yet.  
 
Fibronectin binding proteins (FnBPs) 
FnBPA and FnBPB constitute the FnBP subfamily of MSCRAMMs in S. aureus [77]. 
13 
 
 
 
 
 
Figure 2. Cartoon representation of previously characterized subfamilies of 
MSCRAMM. Reprinted with permission from [29].  
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The cartoon in figure 2b shows relative positions of N-terminus signal peptide, A-
domain (A), Fibronectin-binding repeats, LPXTG motif and cell wall/membrane- 
spanning region. As the name states, proteins in this subfamily bind fibronectin [80, 81]. 
Fibronectin-binding repeats in FnBPA and FnBPB act as a linker and function as a 
ligand binding region [28]. The N2N3 sub-domains of both proteins binds to fibrinogen 
[82]. The A-domain of FnBPs is structurally and functionally similar to Clf-Sdr proteins 
[83, 84].  
 
Collagen adhesin (Cna) protein 
The Cna protein is the only known S. aureus MSCRAMM in this subfamily [28]. The 
cartoon in figure 2C shows relative positions of N-terminus signal peptide, the A-domain 
(A), the B-repeats, the LPXTG motif and the cell wall/membrane- spanning region. 
Unlike other MSCRAMM, the N1N2 sub-domains of Cna comprises of a variant of the 
IgG fold. Cna binds to collagen by a collagen hug mechanism, which is a derivative of 
DLL mechanism [85]. Cna B-repeats differ in sequence from the Sdr proteins B-repeats 
[86]. Cna lacks a flexible linker to project ligand binding region away from cell surface. 
 
MSCRAMM ligand-binding mechanisms 
X-ray crystallography of recombinant N2N3 sub-domains with and without ligand, site 
directed mutagenesis, and amino acid replacements in the ligand peptide helped define 
the MSCRAMM ligand-binding mechanisms. There are two known mechanisms: (i) the 
dock, lock and latch model and (ii) the collagen hug model. 
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Dock lock and latch model 
The N2 and N3 sub-domains of MSCRAMM each adopt an IgG-like fold, which is 
composed of two β-sheets. The N2 sub-domain contains A, B, E, D, D’, D’’, C, F, and G 
strands. The N3 sub-domain contains A’, B’, E’, D’, D1’, D2’, C’, F’ and G’ [87]. The 
amino acid residues connecting the two IgG-like fold form a trench. Ligands dock into a 
trench formed between the two IgG-like folded domains. The ligand peptide aligns either 
parallel or antiparallel to G’ strand in the N3 domain [28, 87, 88]. This docking induces 
a conformational change in the MSCRAMM resulting in a redirection of the C-terminal 
extension of the N3 domain to cover the bound peptide and locking it in the trench. 
Next, the N3 extension contacts the N2 domain by forming a complementary strand in a 
β sheet, thus forming a latch and a stable closed conformation of the ligand/MSCRAMM 
complex (Figure 3) [87, 88].  
 
Collagen Hug model 
Cna binds collagen using a collagen hug model, a variant of the DLL model. Collagen 
hug model consists of ligand docking, locking and latching as seen in DLL model. N1N2 
sub-domains adopt IgG-like folds similar to N2N3 domains in other MSCRAMMs. 
Linker connecting N1 and N2 domain of Cna is longer than the linker between N2-N3 
domains of other MSCRAMMs. Ligand docks in the cavity between the N1-N2 domain 
which results in a redirection of the linker to cover “hug” the bound peptide and locking 
it in place. Next, the C-terminal N2 extension contacts the N1 domain by forming a  
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Figure 3. Dock, lock and latch model. Reprinted with permission from [29]. 
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Figure 4. Collagen hug model. Reprinted with permission from [29]. 
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complementary strand in a β sheet, thus forming a latch and a stable closed conformation 
of the ligand/MSCRAMM complex (Figure 4) [28, 85]. 
 
Function 
Extensive studies of S. aureus MSCRAMMs has shown multiple functions for these 
surface proteins i.e. adhesion, invasion, immune evasion and biofilm formation. Table 2 
provides a comprehensive list of MSCRAMM ligands and functions. 20% of the human 
population is colonized by S. aureus in the anterior nasal cavity. S. epidermidis is a 
ubiquitous skin colonizer [2]. MSCRAMMs bind to host proteins to accomplish two 
goals (i) colonization and (ii) adherence to host tissue to establish infections. ClfB binds 
to human loricrin expressed by squamous epithelial cells. This interaction promotes 
nasal colonization of S. aureus in the nose [89]. ClfB and ClfA both play a role in 
endocarditis, through their interaction with fibrinogen present in blood clot at a wound 
site [90, 91].  
 
Recently, it has been discovered S. aureus can survive within neutrophils and even direct 
invasion of non-phagocytic cells. For example, FnBPA and FnBPB play a critical role in 
causing mastitis by promoting adhesion to epithelial cells in mammary gland and 
subsequent internalization [80, 81, 92]. Invasion of mammalian cells protect the bacteria 
from extracellular host defenses. In the case of S. aureus, internalization also provides an 
opportunity for bacterial toxins to damage the host cell from within.  Upon encounter 
with a pathogen, the host launches innate and adaptive immune responses. To date,  
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MSCRAMM Ligand/mechanism Role in colonization or 
infection 
Reference 
ClfA Binds fibrinogen in 
blood clot  
Endocarditis [91] 
Binds soluble 
fibrinogen  
Immune evasion by 
coating bacteria with 
fibrinogen, septic death 
[93, 94] 
Binds complement 
regulator Factor I 
Reduces 
opsonophagocytosis 
[95] 
Unknown mechanism Critical for Septic arthritis [96] 
ClfB Binds fibrinogen in 
blood clot 
Endocarditis [90] 
Binds to loricin 
expressed by squamous 
epithelial cells 
Nasal colonization [89] 
Cytokeratin 10 Nasal colonization [97, 98] 
FnBPA Binds fibrinogen in 
blood clot 
Endocarditis [82] 
Binds to fibronectin Invasion of epithelial cells 
in mammary gland, 
invasion of endothelial 
cells, mastitis 
[80, 81, 92, 
99]  
Binds to elastin Adhesion to intra-aortic 
patch 
[100]  
Homophilic 
interactions 
Promotes biofilm on a 
biomaterial 
[33, 101] 
FnBPB 
 
Binds to fibronectin Invasion of epithelial cells 
in mammary gland, 
invasion of endothelial 
cells, mastitis 
[80, 81, 92, 
99] 
Homophilic 
interactions 
Promotes biofilm on a 
biomaterial 
[33, 101] 
Cna Collagen triple helix Adhesion to cartilage 
tissue 
[85, 102] 
Complement protein 
C1q 
Inhibition of classical 
complement pathway 
[103] 
SdrC β-neurexin Unknown [104] 
Homophilic interaction Biofilm formation [105] 
Table 2. Functions of known MSCRAMMs. 
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MSCRAMM Ligand/mechanism Role in colonization or 
infection 
Reference 
SdrC Adhere to 
desquamated 
epithelial cells  
Unknown but points 
towards nasal 
colonization 
[106] 
 
 
SdrD Adhere to 
desquamated 
epithelial cells  
Unknown but points 
towards nasal 
colonization 
[106] 
SdrE Binds to complement 
regulator factor H 
Inhibit alternative 
complement pathway 
[107] 
Bbp Binds to soluble and 
immobilized 
fibrinogen 
Delays fibrin formation [108] 
SdrG Binds to fibrinogen  Attachment to catheters [29, 30] 
 
SdrF Binds to collagen Initiation of ventricular 
assist device driveline 
infections 
[31, 53] 
Table 2. Continued 
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MSCRAMMs have been reported to interfere with innate immune responses. Cna binds 
to collagen like stalk of C1q and interferes with its interaction with C1r; thereby, 
inhibiting classical complement pathway [103]. Similarly, SdrE binds and recruits factor 
H to the surface of S. aureus and inhibits the alternative pathway of complement 
activation [107]. An alternative strategy S. aureus utilizes to evade immune response is 
by coating itself with fibrinogen. ClfA, ClfB, FnbpA, FnbpB, Bbp all bind to fibrinogen 
and can potentially create a fibrinogen coat around the bacteria, which shields it from 
innate and adaptive immune responses [82, 93, 108].  
 
Lastly, MSCRAMM participate in biofilm formation through either hemophilic 
interactions or binding to a host protein. S. epidermidis MSCRAMM SdrG binds to both 
soluble fibrinogen and adsorbed fibrinogen on biomaterial, thus promoting biofilm 
formation [29, 30]. Additionally, S. epidermidis MSCRAMM SdrF initiates biofilm 
formation by binding to collagen adsorbed on left ventricular assist driveline [31, 33]. 
On the other hand, SdrC, FnbpA promote biofilm formation through homophilic 
interaction [101, 105]. N2-N3 sub-domain of FnbpA interacts with N2-N3 sub-domain 
of another molecule of FnBPA in a DLL independent mechanism [33, 101].  
 
Mobile genetic elements  
 
The S. epidermidis genome consists of 80% core genes and 20% variable genes [109]. 
The core genes are the genes present in all the strains of a bacterial species. Core 
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genome consists of genes required for survival e.g. DNA synthesis, replication etc. 
Variable genes are present in a single or a subset of strains of a bacterial species. 
Variable genes are often encoded on mobile genetic elements (MGEs) and include 
transcriptional regulators, defense mechanism genes, recombinase and integrase genes 
[109]. MGEs are segments of DNA with intracellular (within the same genome) and 
intercellular (between bacterial cells) mobility [110]. These elements encode proteins 
and enzymes that facilitate their transfer as well as integration into DNA of the new host 
cell. Bacteria adapt by acquiring MGEs encoding a variety of virulence and resistance 
determinants required for surviving selective pressures [110].  MGEs are propagated by 
vertical gene transfer (progeny cells inherit DNA from parent cells) or horizontal gene 
transfer (HGT) [111, 112]. Staphylococci contain types of MGEs described below. 
 
Plasmids 
These are circular or linear, double stranded, self-replicating DNA molecules. Plasmids 
are smaller than the host chromosome and do not contain genes required for the bacteria 
survival. Each Staphylococcus cell carries one or more plasmids with varied gene 
content [112]. Plasmids usually carry genes for their own replication and variable genes 
that are not encoded on host chromosome. In staphylococci, plasmids are either 
transferred through transduction or conjugation (discussed below). Upon entering a new 
host cell, plasmid can either remain as its own unit or integrate into host genome. 
Staphylococcal plasmids vary in size from 1.3 kb to 64.9 kb with majority of the 
plasmids in 20-30 kb size range.  
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Plasmids are notorious for carrying antibiotic resistance determinant genes. S. aureus 
recently acquired vancomycin resistance gene cluster from enterococci through transfer 
of Tn1546 encoded on a conjugative plasmid [113]. The pSTS7 plasmid from S. 
epidermidis mediates resistance to tetracycline, kanamycin and neomycin. pSTS7 has 
partial sequence homology to kanamycin/bleomycin/neomycin resistance plasmid 
pUB110 from S. aureus and tetracycline resistance plasmid pNS1981 from Bacillus 
subtilis [114]. Additionally, plasmid pNE131 from S. epidermidis encodes a methylase 
responsible for resistance to antibiotics macrolide, lincosamide and streptogramin B 
(MLS B) [115].  
 
Bacteriophages 
Bacteriophages, often-called phages, are viruses that infect bacteria. The phage genome 
consists of double stranded or single stranded DNA or RNA. Their size varies from a 
few to several 100 kb [110]. Phages core genome consists of genes required for forming 
head, tail, DNA replication and nucleotide metabolism. These genes are used to identify 
phage in a bacterial genome [116]. Phages can have lysogenic or lytic life cycles. Lytic 
phages replicate inside bacterial host and lyse the bacterial cell for the release of new 
viral progeny. Alternatively, in lysogenic life cycle, phage genome is maintained stably 
in the new host as plasmid or gets integrated in the genome (prophage). Phage DNA then 
replicates with the host genome. Under certain stress conditions, prophage can exit 
lysogenic cycle and turn lytic [117].  
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Prophages can also carry important virulence factors in their genome. Chemotaxis 
inhibitory protein (CHIP), staphylococcal inhibitor of complement (SCIN), leukocidin 
M/F, Pantone-Valentine leucocidin, staphylokinase,  exfoliative toxin A, enterotoxin 
A/G/K/K2/P/Q are critical virulence factors encoded on prophage in S. aureus [112]. 
The ϕSPβ-like prophage in S. epidermidis encodes SesI, which has been suggested as a 
potential marker for invasive capacity of S. epidermidis. SasX, a homologue of SesI in S. 
aureus is also encoded on a similar ϕSPβ-like prophage [118]. The SasX protein in S. 
aureus, enhances nasal colonization, skin and lung disease, and abscess formation [119]. 
  
Transposons and insertion sequences 
Transposons also called as “jumping genes”, are segments of DNA that move around in 
the genome. Transposons can be inserted in core genome or mobile genetic elements like 
plasmids and genomic islands. When inserted within a gene, the transposon can disrupt 
gene expression or function. Transposons can also pick up surrounding genes and move 
them to different genomic site. 
 
Common transposons found in bacteria contain genes for antibiotic resistance. The 
Tn916/Tn1545 family consists of two related conjugative transposons discovered in the 
1970s. Variations of Tn916/Tn1545 have been reported in multiple bacterial species 
including S. aureus and CoNS [120-122]. Tn1545 is a ~ 25 kb transposon carrying 
resistance determinants MLS B-type antibiotics and kanamycin. Tn916 is 18kb in size, 
and confers resistance to tetracycline and its analog minocycline [120]. Staphylococci 
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are notorious for carrying resistance to beta-lactam antibiotics. The β-lactamase 
structural gene and its regulatory genes have been identified on transposon Tn552 as 
well as plasmids and chromosome. Tn552 is closely related to other transposons like 
Tn4002, Tn4201 found in staphylococci [123]. Sidhu et. al. reported presence of Tn552 
in S. epidermidis [124]. 
 
Genomic Islands 
Genomic islands are clusters of genes acquired through horizontal gene transfer. 
Genomic islands share characteristic features: (i) Genomic islands can be anywhere from 
8 kb to 200 kb. (ii) usually have a sequence composition bias i.e. GC content is different 
than GC content of the core genome. (iii) They are often inserted in tRNA genes (iv) 
Insertion of genomic islands creates 16–20 bp flanking direct repeats. (v) and frequently 
have a cluster of genes that offer a selective advantage for the bacteria [125, 126]. These 
genes could encode for virulence factors, fitness, resistance, metabolism or symbiosis. 
Certain genomic islands also encode for an enzyme required for its mobility like 
integrases, transposase and chromosomal cassette recombinases. In other cases, genomic 
islands could have remnant of mobility genes indicating these were once mobile. The 
staphylococci genome has multiple types of genomic islands: immobile genomic islands, 
pathogenicity islands, Arginine catabolic mobile element (ACME) and Staphylococcal 
chromosomal cassette (SCC) [112]. 
 
Sequencing and assembly of the complete genome of S. epidermidis helped to identify 
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υSe1, υSe2, a novel genomic island υSeγ and enterotoxin bearing pathogenicity island 
SePI [69, 127]. The υSe1 in S. aureus carries enterotoxin genes while in S. epidermidis 
RP62a it contains genes for cadmium resistance. S. aureus υSe2 encodes for SEC, TSST 
toxins. On the other hand, υSe2 in S. epidermidis ATTCC12228 isolate contains gene for 
srtC, strain specific sortase and two LPXTG motif containing surface proteins predicted 
to play a role in adhesion to host tissue. υSeγ encoded by both the S. epidermidis isolates 
contains gene cluster for four members of PSM family [127]. Recently, enterotoxin sec3 
and sell bearing pathogenicity island SePI was discovered in S. epidermidis FRI909. Out 
of 200 isolates tested, SePI was only present in one isolate, indicating its rare presence in 
S. epidermidis [69].  
 
ACME is a genetic island first found in S. epidermidis ATCC12228 genome [55, 128]. 
The arc genes and the opp genes are the two main gene clusters present in ACME [128, 
129]. The arc genes encode for enzymes of the arginine deiminase pathway which 
converts L-arginine to ATP, carbon dioxide and ammonia [128]. The opp genes encode 
for oligopeptide permease operon. The Opp operon has multiple functions including 
chemotaxis, quorum sensing, peptide nutrient uptake and more. It is worth noting that 
both arc and opp genes are encoded on the chromosome in staphylococci and other 
bacteria [130, 131].  
 
In S. aureus, ACME has been identified in ST 5, ST22 and ST8 [128, 129, 132]. ACME 
island enhances pathogenic fitness (enhanced colonization and transmission) and is  
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Figure 5. Structural organization of SCCmec. 
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responsible for USA300 S. aureus epidemic in the US [133, 134]. However, it is more 
widespread in CoNS especially S. epidermidis. ~50% of clinical isolates of S. 
epidermidis tested had ACME [135, 136]. ACME is often found together with SCCmec 
(discussed below) inserted either downstream or upstream of SCCmec [128, 137]. 
ACME is inserted at the orfX, in the same location as SCCmec [128, 136]. There are 
three allotypes of ACME: ACME I containing both the opp and arc clusters, ACME II 
containing the arc gene cluster and ACME III containing the opp gene cluster [136].  
 
SCC is another type of genomic island present in staphylococci. There are two types of 
SCC: SCCmec (containing the mec gene) and Non-mec SCC. All SCC elements share 
conserved features: (i) always inserted in 3’ of the orfX gene encoding rRNA 
methyltransferase, (ii) contain ccr genes encoding for site specific recombinases and (iii) 
are flanked by direct repeats.  SCCmec contains genes for methicillin resistance complex 
(mecA, mecR and mecI genes) and chromosomal cassette recombinase complex (ccrA/B 
or ccrC genes). Methicillin resistance gene complex and chromosomal cassette 
recombinases genes are connected to each other and to the ends of the cassette by joining 
regions (J1, J2 and J3) as shown in figure 5. Joining regions encode for genes. Joining 
regions have also been shown to contain genes for resistance to antibiotics and heavy 
metals, and transposons [138]. SCCmec is typed based on the mec gene complex, ccr 
gene complex and sub-typed by J region. Table 3 lists the composition of ccr gene 
complex and mec gene complex present in 11 SCCmec identified to date. SCCmec types  
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SCCmec type ccr gene complex mec gene complex 
I 1 (A1B1) B (IS431-mecA-ΔmecR1-IS1272) 
II 2 (A2B2) A (IS431-mecA-mecR1-mecI) 
III 3 (A3B3) A (IS431-mecA-mecR1-mecI) 
IV 2 (A2B2) B (IS431-mecA-ΔmecR1-IS1272) 
V 5 (C) C2 (IS431-mecA-ΔmecR1-IS431)* 
VI 4 (A4B4) B (IS431-mecA-ΔmecR1-IS1272) 
VII 5 (C) C1 (IS431-mecA-ΔmecR1-IS431)# 
VIII 4 (A4B4) A (IS431-mecA-mecR1-mecI) 
IX 1(A1B1) C2 (IS431-mecA-ΔmecR1-IS431)* 
X 7(A1B6) C1 (IS431-mecA-ΔmecR1-IS431) # 
XI 8(A1B3) E (blaZ-mecALGA251-mecR1LGA251-
mecILGA251) 
        * Two IS431s are arranged in the opposite direction 
        # Two IS431s are arranged in the same direction 
Table 3. The ccr and mec gene complex present in SCCmec types. 
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Figure 6. Schematic representation of SCCmec types. Reprinted with permission 
from  [138]. 
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I-VIII are present in isolates obtained from humans. Structures of SCCmec are shown in 
Figure 6 [138]. 
 
Peptidoglycan, a major component of the bacterial cell wall, is a polymer of long glycan 
chains connected by flexible peptide bridges. Glycan chains are made of repeating 
subunits of β-1,4-linked N-acetyl glucosamine (GlcNAc) and N-acetyl muramic acid 
(MurNAc) [139]. Peptidoglycan synthesis takes place in three different locations in a 
cell. First in the cytoplasm, Uridine diphosphate (UDP)-GlcNAc and UDP-MurNAc are 
generated. A five amino acid chain L-ala-D-Glu-L-Lys-D-ala-D-ala is added to UDP-
MurNAc, which generates parks nucleotide. Second stage occurs at the plasma 
membrane where parks nucleotide is attached to a lipid anchor called undecaprenol 
pyrophosphate, bound to the plasma membrane. Parks nucleotide attached to lipid 
anchor is called Lipid I. Lipid I undergoes further modification by addition of N-acetyl 
glucosamine and a pentapeptide chain, creating Lipid II molecule. Glycine pentapeptide 
chain is added to L-Lys of Lipid I molecule. Next, lipid II molecule is flipped over to the 
outer side of the plasma membrane. Lipid II molecule is attached to the reducing end of 
an existing peptidoglycan chain via a transglycosylation reaction. Further, pentaglycine 
peptide on one Lipid II molecule is crosslinked with 4-D-Ala in the five amino acid 
chain of the other Lipid II molecule by a transpeptidation reaction. Transglycosylation  
and transpeptidation reactions are carried out by Penicillin binding protein (PBP) (Figure 
7) [140]. 
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Figure 7. Synthesis of peptidoglycan for cell wall formation. Reprinted with 
permission from [140].  
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Methicillin is a β-lactam antibiotic of the penicillin class, which inhibits bacterial cell 
wall synthesis. Methicillin inhibits transpeptidation of glycan chains by acting as an  
analog of D-Ala-D-Ala molecules in the five amino acid chain in the Lipid II molecule 
[141]. A complex is formed between methicillin and PBP, which inhibits PBP function 
as a transpeptidase enzyme.  Resistance to penicillin (another β-lactam antibiotic) is 
conferred by β-lactamase enzyme that cleaves a bond in the β-lactam ring of penicillin 
and deactivates the molecule. Methicillin escapes cleavage by by β-lactamase through 
steric hindrance and is therefore, able to target PBP [142].   
 
A new Penicillin binding protein 2’ (PBP2’) confers resistance to methicillin. PBP2’ 
lacks a high affinity site for binding to β-lactam ring of methicillin. In addition, it has a 
reduced rate of complex formation with methicillin compared to PBP [143]. PBP2’ has 
an extended structure compared to PBP and is composed of transpeptidase domain with 
an allosteric site and a transmembrane domain. The binding of D-Ala-D-Ala terminus of 
pentapeptide stem provides the allosteric control. Binding of D-ala-D-ala to the allosteric 
site leads to conformational changes in the protein through formation of salt bridges. 
This conformational change opens up the active site for transpeptidation reaction [144].  
 
The mecA gene in SCCmec encodes PBP2’. The mecA gene expression is increased in 
the presence of methicillin. The mec operon consists of four genes: mecA, mecR1, mecI 
and mecR2 (Figure 8). The mecA gene is transcribed in opposite direction to the other 
genes in the operon. In the absence of methicillin, expression of the mecA gene is  
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Figure 8. The mec operon and its expression in absence/presence of methicillin. 
Reprinted with permission from [142].  
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inhibited by binding of the MecI repressor at mec operator site. MecR1 is a 
transmembrane protein that recognizes methicillin. Upon binding to methicillin, MecR1 
undergoes autocatalytic activation and might be involved in proteolysis of MecI. D-Glu-
D-Lys dipeptide cell wall fragments, generated by disruption of cell wall synthesis bind 
to MecI. This also leads to its dissociation from mec operator site, followed by 
transcription of the genes producing PBP2’, MecI, MecR1 and MecR2. MecR2 is an 
anti-repressor that binds to MecI, leading to its proteolysis and prevents its binding to 
mec operator site [142]. 
 
SCCmec also encodes its own enzymes required for mobility. Once inside the host, 
chromosomal cassette recombinases (CcrA/B or CcrC) are required for integration and 
excision of the SCC elements. CcrA and CcrB complex is needed for effective 
transposition. CcrA is involved in substrate recognition and recombination while CcrB is 
involved in recombination only. Whereas, CcrC can both integrate and excise SCC 
elements by itself. orfX contains an integration site sequence attB at the 3’ recognized by 
Ccr recombinases. Similarly, an attachment site called attSCC is present in circularized 
SCCmec element. Recombinases bring the two sites closer by formation of a tetrameric 
complex. Following DNA cleavage, 180ᴼ rotation of two of the Ccr molecules in the 
tetrameric complex leads to exchange of DNA strands. Re-ligation of DNA leads to 
integration of SCCmec element in the bacterial chromosomal DNA creating two new 
attachment sites called attL and attR. Excision of SCCmec is carried out in similar way 
and generates the original attachment sites attB and attSCC (Figure 9). Insertion of  
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Figure 9. Integration and excision of SCCmec elements.  
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SCCmec cassette in orfX does not change its expression and the stop codon is not altered 
[145].  
 
Horizontal gene transfer 
 
MGEs are transferred amongst bacterial cells through vertical gene transfer or HGT. In 
prokaryotes, HGT occurs in 3 ways in prokaryotes: transformation, conjugation and 
transduction (Figure 10).  Transformation is the direct uptake of exogenous genetic 
material from the surrounding. Staphylococci unlike Bacillus subtilis is not very 
competent [112, 117]. However, recently reported competence genes in S. aureus, are 
controlled by the expression of a novel secondary sigma factor, SigH. The report showed 
that a complete SCCmec type II can be transferred from N315 MRSA strain to MSSA 
strain through natural competence. SigH is only expressed in a fraction of bacterial cells 
[146]. 
 
Conjugation is the transfer of genetic material between bacterial cells by direct contact 
via pilus. Conjugation requires either conjugative plasmids or chromosomally integrated 
conjugative elements (ICEs) including transposons. Conjugative plasmids carry 
conjugative or transfer genes to establish mating pair and transfer plasmid from donor to 
recipient cells. Conjugation plasmids can also mobilize plasmids that contain limited or 
no conjugative genes.  pSK41 is one of the most studied conjugative plasmid families in 
S. aureus. Conjugative pili have not been observed for S. aureus and it is therefore  
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Figure 10. Mechanisms of horizontal gene transfer in prokaryotes. Reprinted with 
permission from [147].  
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believed that DNA is transferred through pores in neighboring bacterial cells. Also, 
frequency of conjugation is S. aureus is higher in biofilms compared to planktonic cells 
[11]. 
 
Transduction is the process of transfer of DNA from one bacterial cell to another by a 
bacteriophage. Phage typically packs its own DNA into the capsid, but under unknown 
conditions bacterial chromosomal or plasmid DNA can be packaged into the phage 
particle. This pseudo-phage particle when released from infected bacterial cell can bind 
to the receptor of an uninfected cell and transfer bacterial chromosomal or plasmid 
DNA. This mechanism is called generalized transduction. Newly inserted DNA lacks 
phage genes and is then integrated into the host bacterial cell genome and do not trigger 
a lytic lifecycle [148]. Scharn C.R. et. al. reported that bacteriophage 80 alpha and 29 
can transfer SCCmec type IV and SCCmec type I respectively from USA 300 MRSA 
strains to methicillin-sensitive USA 300 recipient strains. This transduction occurred at 
the frequency from 3.8x10-9 to 6.9x 10-10. Transduction was dependent on presence of 
penicillinase (beta-lactamase specific for penicillin) plasmid in the recipient strain [149].   
 
CoNS as a reservoir of antibiotic resistance 
 
S. aureus is more virulent that CoNS because of plethora of virulence factors present in 
its genome. Most of the antibiotic resistance determinants and virulence factors in S. 
aureus are encoded on MGEs. CoNS appear to serve as a reservoir for genes encoding 
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virulence factors that can be transferred horizontally to other staphylococcal species 
including S. aureus [150]. Different staphylococcal species share ecological niches 
during their lifestyle as a commensal on human skin. This provides an opportunity for 
MGE exchange through HGT. Widespread mecA gene in S. aureus originated in S. sciuri 
[151].  
 
There is strong evidence suggesting transfer of SCCmec elements from S. epidermidis to 
S. aureus. S. epidermidis SCCmec type IV and S. aureus SCCmec type IVa share a 98-
99% homology at nucleotide level although their genomes do not share that high identity 
[152]. Insertion element IS1272 is present in higher numbers in S. epidermidis than S. 
aureus [153]. Additionally, SCCmec type IV was first observed in S. epidermidis [154]. 
Also, arginine catabolic mobile element (ACME) that contributes to fitness of 
Community associated-MRSA USA300 and a surface protein SasX located on a 
prophage in S. aureus originated from S. epidermidis [150]. 
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CHAPTER II 
A NOVEL MSCRAMM SUBFAMILY IN COAGULASE NEGATIVE 
STAPHYLOCOCCAL SPECIES1 
 
CoNS are important opportunistic pathogens. S. epidermidis, a coagulase negative 
staphylococcus, is the third leading cause of nosocomial infections in the US. Surface 
proteins like MSCRAMMs are major virulence factors of pathogenic gram-positive 
bacteria. Here, we identified a new chimeric protein in S. epidermidis, that we call SesJ. 
SesJ represents a prototype of a new subfamily of MSCRAMMs. Structural predictions 
show that SesJ has structural features characteristic of a MSCRAMM along with a N-
terminal repeat region and an aspartic acid containing C-terminal repeat region, features 
that have not been previously observed in staphylococcal MSCRAMMs but have been 
found in other surface proteins from gram positive bacteria. We identified and analyzed 
structural homologs of SesJ in three other CoNS. These homologs of SesJ have an 
identical structural organization but varying sequence identities within the domains. 
Using flow cytometry, we also show that SesJ is expressed constitutively on the surface 
of a representative S. epidermidis strain, from early exponential to stationary growth 
phase. Thus, SesJ is positioned to interact with protein targets in the environment and 
plays a role in S. epidermidis virulence. 
                                                 
1 This chapter is reprinted with permission from “A Novel MSCRAMM Subfamily in 
Coagulase Negative Staphylococcal Species” by Arora, S., Unhlemann, A.C., Lowy, 
F.D., and Hook, M., 2016. Frontiers in Microbiology, 7: 1-9, Copyright 2016 by 
Srishtee Arora, Ana-Catrine Uhlemann, Franklin D. Lowy and Magnus Hook.  
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Introduction 
 
CoNS, which colonize human skin and mucus membranes, are recognized as important 
opportunistic pathogens. S. epidermidis and S. haemolyticus are the two most prevalent 
CoNS species responsible for causing a significant proportion of device-related, health 
care-associated infections and infections in preterm newborns [2]. S. epidermidis alone is 
the third leading cause of nosocomial infections in the US. S. saprophyticus is the 
second most common cause of uncomplicated urinary tract infections in sexually active 
women between the age of 18 and 35 years [19, 155]. Recent studies have indicated that 
Staphylococcus capitis can cause late onset sepsis in very low birth weight infants in the 
neonatal intensive care unit setting [156, 157] and prosthetic valve endocarditis in adults 
[158]. 
 
Bacterial surface proteins such as CWA proteins have been identified as important 
virulence factors among gram positive bacterial pathogens and play key roles in 
microbial adherence to host tissues, evasion of host defense systems and biofilm 
formation [29, 159]. For example, in S. epidermidis the CWA proteins Biofilm 
associated protein (Bap) [43], Aap [160], SdrF [53], SdrG [30] and Embp [161] all can 
participate in biofilm formation either by mediating bacterial attachment to matrix 
proteins or intercellular aggregation. Furthermore antibodies to the S. epidermidis 
surface protein C (SesC) inhibit biofilm formation, but a molecular function for SesC in 
biofilm formation has not yet been determined [72, 162]. 
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The CWA proteins of gram-positive bacteria are often modular proteins composed of 
various interlinked domains. These proteins can be further divided into families [e.g., 
MSCRAMMs and Serine Rich Repeat Proteins (SRRPs)] based on the presence of 
common characteristic domains [29, 51]. A defining feature of the MSCRAMM family 
is the presence of two tandemly linked IgG-like folded domains, which can engage in 
ligand binding by the DLL mechanism [87, 88]. A subfamily of MSCRAMMs contains a 
repeat (R) region composed of serine-aspartate di-peptide repeats (Sdr), which defines 
the Sdr protein subfamily. In S. aureus, this subfamily includes ClfA, ClfB, SdrC, SdrD 
and SdrE [29, 77]. There are two members of the Sdr subfamily on the surface of S. 
epidermidis; SdrG and SdrF [76]. SdrG binds to human fibrinogen [87]. SdrF binds to 
Type I Collagen and is involved in the initiation of left ventricular assist device driveline 
infections [53]. 
 
The SRRP family of CWA proteins is defined by the presence of a serine repeat region 
(SRR), which is similar to the R region of Sdr proteins in that it contains serine dipeptide 
repeats but with either alanine, valine or threonine as the partner residue. SRRPs have a 
N-terminal signal sequence, at most two unique non-repeat (NR) regions, two SRRs 
flanking the NR region(s) and motifs needed for cell wall anchoring at the C-terminus 
[51]. Based on the crystal structures of NRs of two SRRPs; Fap1 from S. parasanguinis 
and GspB from S. gordonii, the NR region can be further subdivided into different 
domains. Both proteins contain one IgG-like folded sub-domain in the NR region [163, 
164]. The SRRPs are common in streptococci but also have been found in S. aureus  
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(SraP in strain N315, [165]), S. haemolyticus (SH0326 in strain JCSC1435, [18]) and S.  
epidermidis (SE2249 in strain ATCC 12228, [166]). 
 
Although the pathogenic mechanisms of S. epidermidis are attracting more attention, the 
possible roles of CWA proteins in these infections need to be further examined. 
Furthermore, CWA proteins on other CoNS are even less well characterized. We here 
report on the discovery of a previously unknown CWA S. epidermidis protein that we 
demonstrate is a prototype of a novel subfamily of CoNS MSCRAMMs. 
 
Materials and methods 
 
Bacterial strains and growth conditions 
S. epidermidis strains were routinely grown in Tryptic Soy Broth (TSB) medium 
overnight at 37°C at 200 rpm. Growth curves were generated by inoculating fresh TSB 
media with overnight inoculum to a starting OD600 of 0.03, followed by incubation at 
37°C at 200 rpm. S. epidermidis strain 3094 and 2111 are clinical isolates obtained from 
patients with left ventricular device driveline infections. S. epidermidis 3094 was used as 
a source for cloned constructs. Escherichia coli strains XL1Blue and BL21 AcellaTM 
were grown in Luria-Bertani (Sigma) medium with appropriate antibiotics at 37°C. 
 
Identification of SesJ structural homologs 
Bacterial genome sequences in the NCBI database were searched for proteins with 
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similarity to the SesJ protein using BLAST. New proteins were only accepted if they 
contained N-terminal Repeats (NTRs) at the N-terminus and repeats at the C-terminus. 
Search results were further analyzed to select for proteins that contained a N-terminus 
signal sequence, A-region, B repeats, a LPXTG motif, transmembrane domain followed 
by a positively charged C-terminal amino acid sequence. Online bioinformatics tools 
were used to characterize protein sequences from the BLAST search. The repeat 
domains were identified visually and using the Internal Repeat Finder2 algorithm. 
Protein secondary and tertiary structure was predicted using Protein Homology/analogY 
Recognition Engine V 2.0 (Phyre2)3. Sequence alignment and protein identity was 
calculated with Clustal Omega algorithm program4. N-terminus signal sequence was 
predicted using SignalP 4.1 server5. Hydrophobic transmembrane domain was predicted 
using TMHMM Server v. 2.06. 
 
Construction and purification of histidine-tagged fusion proteins 
rSesJ258-637 protein was expressed with hexa-histidine tag at the N-terminus using the 
expression vector pQE30 (Qiagen). PCR primers used were SdrS N2N3 fwd 
(TAGGGATCCCCAGAGGTTGATTCCGAAGTATTAG) and SdrSA rev 
                                                 
2 http://nihserver.mbi.ucla.edu/Repeats/ 
 
3 http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index 
 
4 http://www.ebi.ac.uk/Tools/msa/clustalo/ 
 
5 http://www.cbs.dtu.dk/services/SignalP/ 
 
6 http://www.cbs.dtu.dk/services/TMHMM/ 
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(TAGGTCGACCTAAAGTTTTTCATTGCCAGTAGCAAC). Genomic DNA from S. 
epidermidis strain 3094 was isolated using UltraClean® Microbial DNA Isolation kit 
(MO BIO Laboratories, Inc.). Expression cultures were induced with IPTG and protein 
was purified using nickel-affinity chromatography and anion-exchange chromatography 
as described previously [28]. Binding buffer (20 mM sodium phosphate, 1 M NaCl, pH 
8.0), wash buffer (20 mM sodium phosphate, 1 M NaCl, 25 mM Immidazole) and 
elution buffer (20 mM sodium phosphate, 1 M NaCl, 500 mM Immidazole, pH 8.0) were 
used for nickel-affinity chromatography. Binding buffer (20 mM Tris, pH 8.0), wash 
buffer (20 mM Tris, 50 mM NaCl, pH 8.0) and elution buffer (20 mM Tris, 500 mM 
NaCl, pH 8.0) were used for anion-exchange chromatography. 
 
Flow cytometry 
To determine surface expression of SesJ by flow cytometry, bacteria were grown for 4 h 
in TSB broth from an inoculum with an OD600 of 0.03. Collected and washed cells were 
labeled with preimmune or SesJ antiserum followed by Alexa Fluor 488 conjugated goat 
anti-rabbit IgG as described previously. Cells were fixed with 3% paraformaldehyde in 
PBS and analyzed with BD AccuriTM C6 cytometer. Polyclonal antibodies against 
rSesJ258-637 were raised in rabbit (Rockland Immunochemicals Inc.). Pre-immune sera 
was tested for reactivity to SesJ using ELISA before selecting an animal for antibody 
production. 
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Sequence logo 
Sequence logo was generated using frequency plot at WebLogo online program7 [167, 
168]. Custom color scheme as described in the figure legend was used to generate the 
graph. 
 
PCR screening 
Ninety five coagulase-negative Staphylococcus colonizing and infections isolates were 
used to determine the distribution of the sesJ gene, including 64 isolates from a study on 
the epidemiology of S. epidermidis colonization and infection in left ventricular assist 
device individuals [169]. DNA from picked colonies was amplified using primers SdrS-
F 5′-GAGCACAGACAATTCGACTTCAAATC and SdrS-R 
TCAGCATATTCCGGCATATCTACTG and PCR products were sequenced for 
confirmation. 
 
Results 
 
Sequence analysis of the SesJ protein 
While examining the sequence variation of SdrG in published S. epidermidis genomes, 
we discovered a gene encoding a SdrG-like but clearly distinct CWA protein that we 
have called SesJ (GenBank accession number: KU935462) according to the established 
nomenclature. The deduced full length SesJ protein in strain 3094 is 1047 amino acids 
                                                 
7http://weblogo.berkeley.edu/logo.cgi  
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long (Figure 11A). The predicted molecular mass of the mature SesJ protein after 
cleavage of the signal sequence and processing by sortase is 105.82 kDa. Amino acid 
sequence analysis of the full length protein revealed that SesJ has 41 and 40% sequence 
identity to SdrG (GenBank accession number: AAF72510.1) and SdrF (GenBank 
accession number: AAF72509.1), respectively. SesJ is a multidomain protein that 
contains, starting from the N-terminus, a 44 amino acid long signal sequence, a NTR 
region, an A-region, two B repeats, an aspartic acid containing repeat (ACR) region and 
typical cell wall anchoring sequences such as a LPXTG motif, a hydrophobic membrane 
spanning region and a short cytoplasmic positively charged tail (Figure 11A). 
 
SesJ is a novel chimeric MSCRAMM 
MSCRAMMs bind to their ligands through the DLL mechanism [87, 88]. This binding 
mechanism involves characteristic structural features in the MSCRAMM A-region 
including two adjacent IgG-like folded domains where a conserved TYTFTDYVD-like 
motif is present at the “back” of the latching trench in the first domain in the tandem and 
a latch sequence at the C-terminal extension of the second domain. A latch sequence is 
not a conserved sequence of amino acids but consists of small uncharged, polar and non-
polar residues [87]. Tertiary structure prediction using the PHYRE2 fold recognition 
server [170] indicated that residues 269–634 in the A-region of SesJ are highly likely to 
adopt two IgG-like folds (100% confidence level). The predicted structure of the two 
IgG-like domains in SesJ is very similar to the crystal structure determined for the N2N3 
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Figure 11. Comparison of SesJ with other structurally related proteins. 
(A) Schematic representation of S. epidermidis surface proteins SesJ, SdrG, SdrF and 
Aap. Cartoons show the relative position of NTRs (SesJ and Aap) to other domains. The 
number in red above the individual domains represents its identity to the corresponding 
SesJ domain. The signal sequence is shown in white, NTRs in green, A-region in pink, B 
repeats in yellow, R region and ACR region in gray, collagen triple helix in orange, and 
cell wall spanning region and cytoplasmic tail in blue. LPXTG motif is shown using a 
black triangle. (B) Modeled 3D structure of the A-region of SesJ comprising two IgG-
like folded domains compared to the crystal structure of SdrGN2N3. (C) Structure 
predictions of B1 (yellow), B2 (green) repeat of SesJ, along with an overlay of SesJ B1 
(yellow) and B2 (green), and SesJ B1 (yellow) with SdrD B1 (orange) repeat.  
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Figure 11. Continued. 
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Protein Trench motif∗ Latching sequence 
SesJ VYTFTDYVN GANGVATG 
ScsJ VYTFTDYVN GANGVATG 
ShsJ KYTFTDYVN GANGIAQG 
SdrI TYTFTNYVD GSSTAQG 
 ∗ Residues in red indicate conserved residues amongst the proteins 
Table 4. Conserved motifs in the A-region of SesJ structural homologs. 
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domain of SdrG [87] (Figure 11B). This SesJ segment furthermore contains the 
sequence, VYTFTDYVN at the expected positions for a latching trench in the first 
domain of the predicted IgG-like tandem. In addition, a putative latch sequence 
GANGVATG is present in the extension of the second IgG-like folded domain of SesJ. 
The presence of a latch sequence and a conserved TYTFTDYVD-like motif in the N2N3 
sub-domain indicates that SesJ could bind a ligand peptide by the DLL mechanism 
(Table 4). In summary, the A-region of SesJ contains the characteristic IgG-like folded 
tandem of a MSCRAMM. 
 
As a result of the unusually short N1 region that connects the N2N3 tandem to the 
preceding NTR region, the A-region of SesJ (378 amino acids) is smaller compared to 
the A-regions of SdrG (546 amino acid) and SdrF (624 amino acid). Sequence 
comparison shows that the amino acid sequence of the SesJ A-region is 29 and 26% 
identical to the comparable A-region segments of SdrG and SdrF, respectively  
(Figure11A). Similar levels of sequence identity are also seen between the A-regions of 
SesJ and the various S. aureus MSCRAMMs. 
 
Staphylococcal MSCRAMMs do not usually contain a NTR domain, which is found in 
SesJ between the signal sequence and the A-region (Figure 11A). The NTR domain of 
SesJ is composed of a 15 amino acid long sequence repeated 10 – 13 times depending on 
the strain (Table 5). A NTR domain is also found in one other CWA protein from S. 
epidermidis; Aap, where it is composed of a variable number of a 16 amino acid long 
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Protein Sequence of NTR∗ Number/Length of repeat sequence 
SesJ –––––EAPSKEEAPSNEATN 13/15 
ScsJ –––––EEPSKEEATSKEVTN 8/15 
ShsJ –––––EQASTEEKADTT––– 24/12 
SdrI –––––EPATKEEAATTE––– 23/12 
Aap EAPQSEPTKTEEGSNA–––– 12/16 
                      ∗ Residues in red indicate conserved residues amongst the proteins 
 Table 5. Summary of NTRs of SesJ structural homologs. 
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sequence (Table 5). There is a low level of sequence identity throughout the Aap 
(GenBank accession number: AAW53239.1) and SesJ proteins (Figure 11A). The NTRs 
of the two proteins show intriguing similarities (further discussed below) but structure 
prediction show that the A-region of Aap is likely to adopt a lectin type fold, which is 
distinctly different from that of the characteristic MSCRAMM tandem [76]. 
 
SesJ contains two B repeats that are composed of 110 – 111 amino acids, similar in 
length to B repeats of the Sdr subfamily of staphylococcal MSCRAMMs. The SesJ B 
repeats show 63–69% sequence identity to B repeats of SdrG and SdrF (Figure 11A). 
Similar to SdrG and SdrF, the B repeats of SesJ also harbor predicted Ca2+ binding sites 
[171]. The predicted structures of SesJ B1 and B2 are shown (Figure 11C) and these are 
similar to the crystal structure determined for the S. aureus SdrD B1 [172]. On the other 
hand the crystal structure of the Aap B domain, which consists of two sub-domain G5 
and E [173, 174] is very different from those predicted for the SesJ B domains. 
 
The ACR region of SesJ is distinct from the SD repeated dipeptide characteristic of the 
Sdr protein subfamily of staphylococcal MSCRAMMs. A 20 amino acid long motif 
[SESTSESDSESHSDSES(H/D)SD] is repeated in the ACR region of SesJ. This type of 
arrangement is similar to the SRRs of SRRPs, which also are composed of longer motifs, 
e.g., SAS(T/E)SASTSASV in S. gordonii Challis [51]. We propose to name this segment 
ACRs since structural homologs of SesJ found in other CoNS species (see below)  
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contain similar C-terminal repeat motifs where an aspartic acid (rather than serine) is the 
conserved residue. 
 
These comparative analyses reveal that SesJ is a new unique chimeric protein that has 
acquired structural motifs from other families of CWA proteins. The NTR are related to 
the corresponding segment of Aap, the IgG-like folded domains have all the features of a 
MSCRAMM and the ACR region resembles the SRR of streptococcal SRRPs. 
 
SesJ is expressed on the surface of S. epidermidis 
The deduced amino acid sequence of SesJ suggests that this protein could be expressed 
on the bacterial surface as a cell wall anchored protein. We verified by flow cytometry 
that SesJ in fact was expressed on the surface of S. epidermidis strain 3094 when 
bacteria were grown to mid exponential phase, 4 h (Figure 12A). S. epidermidis strain 
2111, which does not have the sesJ gene, was used as a negative control to study 
expression of SesJ. The SesJ antisera did not cross react with any surface protein on the 
S. epidermidis 2111 strain. Similarly, pre-immune sera and secondary antibody alone did 
not bind to surface molecules on the S. epidermidis 3094 strain (Figure 12A). We next 
generated a growth curve (Figure 12B) and looked for expression of the protein at 
different time points during the growth curve. SesJ was constitutively expressed on the 
surface of S. epidermidis strain 3094 throughout the growth curve (Figure 12C). 
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Figure 12. Detection of SesJ expression on the surface of S. epidermidis by flow 
cytometry. (A) Comparison of SesJ expression on the surface of sesj+ S. 
epidermidis 3094 (solid red line), sesj- S. epidermidis 2111 (solid green line), S. 
epidermidis 3094 treated with pre bleed serum and secondary antibody (solid black line) 
and S. epidermidis treated with secondary antibody only (solid blue line). (B) Growth 
curve of sesj+ S. epidermidis strain 3094 in red line. Three hours is represented by black 
solid circle, 5 h by yellow solid circle, 8 h by green solid circle, 12 h by magenta solid 
circle and 25 h by blue solid circle. (C) Comparison of SesJ expression on the surface 
of sesj+ S. epidermidis strain 3094 at 3 h (solid black line), 5 hrs (solid yellow line), 8 h 
(solid green line), 12 h (solid magenta line), 25 h (solid blue line). 
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Figure 12. Continued. 
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Structural homologs to SesJ are present in other CoNS 
We then searched for structural homologs in available sequenced genomes in the NCBI 
genome database for ORFs that contained NTRs and ACR region. Search results were 
further sorted for the presence of an A-region, B repeats and a LPXTG motif. We 
identified structural homologs of SesJ in S. capitis, S. haemolyticus and S. saprophyticus 
(Figure 13A). Two of these had not been previously identified and we have named these 
proteins ScsJ (S. capitis Strain CR01, GenBank accession number: WP_016898462.1) 
and ShsJ (S. haemolyticus strain JCSC1435, GenBank accession number: BAE03349.1). 
We found that the structural homolog in S. saprophyticus has already been reported and 
named SdrI (S. saprophyticus strain 7108, GenBank accession number: AAM90673.1) 
[175]. All these SesJ structural homologs contain a NTR region, an A-region, two B 
repeats and an ACR region as well as the characteristic cell wall anchoring motifs. The 
predicted lengths of the proteins vary considerably from 1048 to 1893 residues due to 
variations in the NTR and ACR regions. 
 
The A-regions of these proteins are similar in length and range from 378 amino acid to 
420 amino acid (Figure 13A). Tertiary structure prediction using the PHYRE2 fold 
recognition server [170] indicated that residues in the A-region of the identified 
structural homologs is highly likely to also adopt the MSCRAMM characteristic IgG- 
domain contains a putative latch sequence (Table 4). The B repeats, which are of the Sdr 
protein types are similar in size (range from 108 amino acid – 120 amino acid) and 
contain putative Ca2+ binding sites. 
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Figure 13. SesJ structural homologs in other CoNS species. (A) SesJ structural 
homologs have the same relative position of structural domains. The number in red 
below the individual domains represents its identity to the corresponding SesJ domain. 
Numbers in black represent the end of domain. Signal sequence is shown in white, NTRs 
in green, A-region in pink, B repeats in yellow, ACR region in gray, and cell wall 
spanning region and cytoplasmic tail in blue. LPXTG motif is shown using a black 
triangle. (B) Predicted structures of ScsJ239-559, SdrI440-755, ShsJ462-782 and overlay of 
SesJ269-634 (blue) with ScsJ239-559 (green). 
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Figure 13. Continued. 
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like folded tandems (100% confidence; Figure 13B). The conserved TYTFTDYVD-like 
motif is found in the first IgG-like domain and the extension of the second IgG-like  
 
SesJ is most similar to ScsJ from S. captis with sequence identity of 82 and 96% for the 
A-region and B repeats, respectively. The A-region of SesJ has about 62% identity with 
ShsJ A-region but less than 30% identity to that of SdrI. The B repeats are relatively well 
conserved in all identified members of this subfamily. B2 repeats are most conserved 
with over 75% identity whereas the B1 repeats show slightly more variations (up to 
50%) (Figure 13A). This suggests that the A-region of these proteins may interact with 
different ligands. 
 
The repeats in the ACR region of the proteins vary in amino acid composition and length 
of the repeat motif. ScsJ has the same residues in the ACR region as SesJ and a similar 
motif, i.e., SESESESHSDSESHSDSEST. ShsJ has a 12 amino acid repeat motif 
S(T/Q)SDSES(T/Q)SDSE which is shorter than repeat motifs in the ACR region of SesJ 
and ScsJ. SdrI has both serine-aspartic acid dipeptide and alanine-aspartic acid dipeptide 
repeats with a repeat motif SD(1-2)AD(1-5). 
 
The NTRs contain a conserved motif 
The presence of NTRs defines this MSCRAMM subfamily but the number, length and 
sequence of the individual repeat units vary among the identified subfamily members 
(Table 5). The repeat units are rather long; 12–15 residues and are composed of mostly 
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hydrophilic amino acids. Within NTRs of individual proteins, the sequence in the first 
and last repeat units diverges somewhat from the sequence of repeats in the core of the 
NTRs. Despite the extensive variation among the sequences of different NTRs, an eight 
amino acid long conserved motif can be identified (Figure 14). Intriguingly the 16 amino 
acid long repeat unit in the NTR of Aap also contain a variant of the core motif 
[E∗∗∗(K/T)EE] found in NTRs of SesJ homologs (Table 4). 
 
Prevelence of SesJ structural homologs in CoNS 
We examined 95 S. epidermidis isolates to determine the prevalence of the sesJ gene. 
Seventeen isolates (18%) were positive and the sesJ gene was present in both colonizing 
and infectious isolates. Furthermore, 4/26 (15%) S. capitis bloodstream isolates were 
positive for the scsJ gene. These frequencies are similar to the reported presence of sdrI 
(11%) in S. saprophyticus UTI samples [175]. Thus, members of the new subfamily of 
MSCRAMMs are present in 11–18% of the examined CoNS isolates. 
 
Discussion  
 
Pan genome sequence analysis has revealed the plasticity of the CoNS species genomes 
[18, 109]. These include CoNS genome changes by the addition of new genes, which can 
alter the virulence potential of the different subspecies. Sequencing of more genomes 
aids in the identification of new virulence factors. In this study, we identified and 
characterized a novel MSCRAMM SesJ, which is a chimeric protein with structural 
63 
 
 
 
 
Figure 14. Conserved motif in the NTRs of SesJ structural homologs. Sequence logo 
of conserved 8 amino acid motif amongst all the structural homologs. Basic residues are 
colored in green, the acidic residues in red, the neutral ones in blue, the hydrophobic 
ones in yellow and remaining residues in orange. 
 
 
 
 
 
 
 
64 
 
features characteristic of staphylococcal MSCRAMMs. The NTR and ACR regions of 
SesJ are not found in other MSCRAMMs but are related to similar domains in Aap and 
SRRPs, respectively. Furthermore, SesJ is a prototype of a new subfamily of 
MSCRAMMs. This newly identified family consists of the structural homologs SesJ, 
ScsJ, ShsJ and SdrI, present in ∼11–18% of S. epidermidis, S. capitis, S. haemolyticus, 
and S. saprophyticus, respectively. We also verified that SesJ is expressed constitutively 
on the surface of S. epidermidis. 
 
Protein families based on structural homology have been reported before. Many gram 
positive bacteria express members of a family of structurally related collagen binding 
proteins where CNA of S. aureus is a prototype [102]. Similarly, the SRRPs constitute a 
family of structurally related proteins present in different streptococcal and 
staphylococcal species [51]. Structural homologs of Bap are present in S. epidermidis, S. 
chromogenes, S. hyicus, S. xylosus, S. simulans as well as in S. aureus [43]. 
 
The S. aureus MSCRAMMs have been studied in most detail. Although these proteins 
all have sequence features required for the structural organization of MSCRAMM their 
overall sequences can vary significantly [28, 77]. These sequence variations allow 
individual MSCRAMMs to have different functions, target different ligands or different 
sequences in the same ligand. For example, fibrinogen is a ligand for many of the S. 
aureus MSCRAMMs but ClfA, ClfB and Bbp bind to different sites in the fibrinogen 
molecule. The sequence variations seen among the SesJ like proteins in different CoNS 
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suggests that these proteins do not necessarily target the same ligand or even have the 
same function in the different species. 
 
The C-terminal repeat regions of Sdr proteins and SRRPs are hypothesized to extend the 
ligand binding domain, i.e., the A-region of Sdr proteins and NR region of SRRPs, away 
from the cell surface to prevent obstruction of ligand binding by the cell wall [51, 78]. 
The C-terminal repeat regions of Sdr proteins and SRRPs are often glycosylated. SRRPs 
are encoded at loci harboring genes for two glycosyltransferases. Sdr proteins also have 
two glycosyl transferase sdgA, sdgB gene encoded downstream of SdrC/D/E proteins 
[176]. Likewise, two genes predicted to encode glycosyl transferases are located 
immediately upstream of the sesJ gene (not shown) and we therefore speculate that SesJ 
is glycosylated. These observations indicate that SesJ is subjected to similar post 
translational modifications as the Sdr proteins and the SRRPs. 
 
Cell wall anchored proteins of gram positive bacteria contain a characteristic C-terminal 
region where the LPXTG motif is recognized by the transpeptidase sortase, which 
covalently attaches the protein to the peptidoglycan on the surface of the organism. Flow 
cytometry confirmed that SesJ is present on the surface of S. epidermidis. Furthermore, 
the protein is present from early logarithmic to late stationary phase in strain 3094. In S. 
aureus, expression levels of MSCRAMMs can vary during the growth phase. For 
example, expression of FnbpA on the surface of S. aureus Newman increases during late 
logarithmic phase and decreases in the late stationary phase. In contrast, ClfB increases 
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during early logarithmic phase and disappears at early stationary phase [177]. The 
expression of SdrG on the surface of S. epidermidis strain 0-47 was not induced under 
the tested in vitro growth conditions but increased over 30 fold in 3 h in a murine 
infection model [178]. Thus the expression of Sdr proteins on staphylococci can differ, 
depending upon the nature of the protein and the environment, and these variations may 
relate to the role of the proteins in the pathogenic mechanism of the organism. 
Additional studies of the expression of SesJ in different strains and under different 
conditions are warranted and can provide clues on the role of the encoded protein in the 
life of S. epidermidis. 
 
The A-region is the primary ligand binding region of MSCRAMMs, which often uses 
the DLL mechanism to engage the targets. SdrGN2N3 binds to a specific sequence in the 
N-terminal section in the β-chain of human fibrinogen by this mechanism [29, 88]. 
However, B repeats may also engage in ligand binding. For example SdrF binds Type I 
collagen via its B repeats in a temperature dependent manner [179]. MSCRAMMs bind 
to host proteins and can mediate bacterial adhesion, evade immune response as well as 
participate in biofilm formation. Both SdrG and SdrF initiate biofilm formation by 
binding to human fibrinogen and Type I collagen, respectively [53, 87]. Aap participates 
in both the initial attachment phase, where a region containing the NTRs and the A 
domain is required, and in the accumulation phase, where the B domains seem to be 
involved [174, 180]. SRRPs acts as adhesins and colonize host tissues by forming 
biofilms. SesJ’s similarity to MSCRAMMs and domains from proteins involved in 
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biofilm formation, leads to a speculation that SesJ might be involved in biofilm 
formation and/or interact with host proteins. The interactions of SesJ and its possible 
role in S. epidermidis pathogenesis are currently under investigation. 
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CHAPTER III 
SESJ AND PLS ARE PRESENT IN A COMPOSITE SCCmec ELEMENT 
 
Introduction 
 
S. epidermidis is an opportunistic pathogen associated with infections in patients with an 
implanted foreign body or a compromised immune response [2, 7, 15]. With advances in 
medicine, the number of patients with both an implanted foreign body and a suppressed 
immune system has increased. These patients carry a high risk for infections and the 
increased misuse of antibiotics has exacerbated this condition.  S. epidermidis has 
successfully thrived in this ecological niche, establishing itself as a successful 
nosocomial pathogen. S. epidermidis undergoes frequent genetic recombination leading 
to well-adapted clonal lineages e.g. CC2 [181, 182]. Using MLST, the genetic 
background of infectious isolates has been identified around the globe. These studies 
revealed that multiple sequence types (STs) are capable of causing infection. ST2, the 
founder sequence type of clonal complex 2, is the most predominant and geographically 
widespread clone [181-183].  A high frequency of genetic recombination within CC2 has 
resulted in an unusually large number of sequence types in this genetic lineage. These 
studies also provided clues to the epidemic nature of S. epidermidis [50, 182, 183]. 
Perhaps, S. epidermidis has been successful as an opportunistic pathogen because of its  
capability of high frequency genetic recombination and gene acquisition, especially the  
acquisition of antibiotic resistance determinants.  
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70-90% of S. epidermidis clinical isolates are methicillin resistant and carry the mecA 
gene present in the SCCmec element [50, 183]. The SCCmec elements carrying the 
mecA gene are widespread among coagulase negative staphylococci [184-187]. To date, 
XI SCCmec elements have been identified in staphylococci, 8 of which are found in the 
human isolates [138]. SCCmec elements have four characteristic features (i) the presence 
of methicillin resistance gene mecA, (ii) the presence of cassette recombinases ccrA/B or 
ccrC (iii) insertion at integration site sequence att in the orfX gene and (iv) the presence 
of flanking direct repeats on both sides of the integrated SCCmec [185]. SCCmec Type 
IV is the most frequent SCCmec represented in S. epidermidis clinical isolates [180, 
181]. In addition, SCCmec Type I, II, III, V, VI, VII also have been identified in S. 
epidermidis clinical isolates collected from different patient types and environments 
[189-191].  
 
Genetic recombination has led to multiple novel configurations of the SCC elements 
deviating from the identified types and sub-types. Pseudo elements missing either the 
recombinase genes (ψSCCmec) or a functional mec gene complex have been described 
[188, 192-194]. Additionally, some staphylococci isolates contain more than one 
SCCmec element [184, 186]. A study by Zong et. al. reported that 23 out of 84 
methicillin resistant CoNS had more than one SCCmec element [184].  Similarly, 
SCCmec elements with two set of recombinase genes have been identified [195]. Lastly, 
some SCC non-mec elements contain virulence genes instead of the mecA gene. For 
example, SCCcap1 contains the genes for capsular polysaccharide while SCCHg carries  
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the mercury resistance operon [196-198].  
 
CWA proteins are critical for establishing a bacterium as a commensal and a pathogen 
[28]. CWA proteins are in direct contact with the host. Hence, it is not surprising that 
CWA proteins have multiple functions e.g. interact with host proteins, promote bacterial 
survival and evade the host immune response to establish infection. The MSCRAMM 
family is one of the well-characterized CWA protein families in staphylococci. 
MSCRAMMs contain two tandemly linked IgG-like folded domains required for 
binding the ligand by DLL mechanism [87, 88, 107, 199, 200]. Many MSCRAMMs are 
critical virulence factors involved in adhesion, invasion, and immune evasion of the 
bacteria. These functions are critical for establishing an infection in the host [30, 31, 33, 
80, 89, 103]. We recently reported on the new NTR containing subfamily of 
MSCRAMMs present in coagulase negative staphylococci. S. epidermidis surface 
protein SesJ is the prototype of the new NTR containing subfamily of the MSCRAMMS 
[201].  
 
Bacteria can adapt to selective pressure by acquiring MGE encoding antibiotic resistance 
determinants and virulence factors [43, 110]. Cell wall anchored proteins present in 
MGE provide selective advantage to bacteria [119].  For example, Plasmin sensitive 
protein (Pls) is present in SCCmec Type 1 [202, 203]. Pls plays a role in biofilm 
formation through the G5 repeats as well as the glycosylated serine aspartate dipeptide 
repeat region [204, 205]. In a mouse septic arthritis model, the presence of the pls gene 
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also led to more frequent joint infection and severe arthritis [206]. SesJ protein is only 
present in the 18% of the previously tested S. epidermidis clinical isolates [201]. We 
hypothesized that the sesJ gene is present in a mobile genetic element. Here we report 
the presence of S. epidermidis cell wall anchored protein SesJ in a composite SCCmec 
element. We also discovered that the pls gene is present in SCCmec Type IV in S. 
epidermidis clinical isolates.  
 
Materials and methods 
 
Isolates  
Serial isolates from blood were collected for the cancer patients that presented with 
symptoms of bloodstream infections at MD Anderson hospital, Houston, Texas.    S. 
epidermidis isolates were confirmed using MALDI-TOF.  
 
Multilocus sequence typing and clonal complex determination 
The draft genome assemblies of the isolates were utilized to determine the MLST 
by batch sequence query of the Bacterial Isolate Genome Sequence Database (BIGSdb) 
[207].  Clonal complexes were determined by the eBURST algorithm, and displayed by 
PHYLOViZ software v2 [208]. The most exclusive group definition used for eBURST 
algorithm included STs within the same group if they share identical alleles at six or 
seven of the seven MLST loci with at least one other ST in the group.  
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Library preparation  
Genomic DNA for Illumina sequencing was extracted using the MasterPure Kit 
(Illumina Inc., San Diego CA) from cultures grown overnight in Muehller-Hinton (MH) 
broth at 37º C. 10 µg of gDNA was used for paired-end sequencing on the Illumina® 
instrument (Illumina, Inc. San Diego, CA) using TruSeq chemistry at the MD Anderson 
Sequencing and Microarray Facility. Genomic DNA for Pacbio sequencing was 
extracted using phenol/chloroform extraction from overnight cultures. The Pacific 
Biosciences guidelines for preparing 20 kb SMRTbell template were used to create a 
large insert library.  
 
Genome Sequencing  
Short read quality for reads generated through Illumina sequencing was assessed using 
the FASTQC toolkit (Babraham Bioinformatics). Adaptors as well as low quality reads 
were trimmed using Trimmomatic v 0.33 [209]. Genome assembly for short reads was 
performed using SPAdes v 3.9.1 [210].  28 genomes assemblies either failed, or were 
deemed poor (> 300 contigs) using SPAdes assembly, were assembled with SeqMan 
Ngen v 14.1 (DNASTAR® Inc, Madison WI). Custom scripts were used to determine 
the average depth of SPAdes generated draft genomes, and remove contigs with less 
than 300 bp and the phi X 174 sequence. This pipeline was implemented on the high 
performance computing cluster at MD Anderson. HGAP pipeline was implemented for 
de novo genome assembly of PacBio reads [211]. PacBio assembly results were 
corrected by mapping paired-end Illumina short reads using Bowtie2 v 2.2.3 [212]. 
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SCCmec typing  
 SCCmec type was determined in silico by typing the combination of mec complex class 
and the type of ccr complex. Different mec gene complexes and ccr gene combinations 
were queried in the assembled genome sequence data of all the study isolates. The 
presence of the mec gene complex and the ccr gene complex was further confirmed by 
visualization of read alignment across the entire genome. A SCCmec element was 
considered typeable if it contained a previously known combination of the mec gene 
complex and the ccr gene complex.  
 
Determination of presence of virulence genes 
Known S. epidermidis virulence factor gene or protein sequences were queried in the 
assembled genome sequence data of the study isolates. Protein sequence for SesJ 
(accession number ANG65522.2), Pls (accession number BAA86640.2), Ebh (accession 
number AAW55290.1), Aae (reference sequence number NP_765874.1), Aap (accession 
number AAW53239.1), SdrF (accession number AAF72509.1), SesC (accession number 
AAW53125.1), AltE  (accession number AAW53968.1), SdrG (accession number 
AAF72510.1), SesI (accession number AAW54982.1) were used to query the assembled 
genomes. Nucleotide sequence for icaRADBC operon (accession number U43366.1), 
Type 1 agr operon (accession number Z49220.1), Type 2 agr operon (accession number 
FJ707317.1), Type 3 agr operon (accession number CP009046.1; region 
607512..611854) were used to query the assembled genomes. The presence of the gene  
was further confirmed by visualization of read alignment to the virulence gene. 
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MB1048 2 Y 1 Y IV Y N Y Y Y Y Y Y Y N 
MB1119 2 Y 1 Y NT1 N N Y Y Y Y Y Y Y N 
MB1145 2 Y 1 Y NT3 N N Y Y Y Y Y Y Y N 
MB1153 2 Y 1 Y NT4 N N Y Y Y Y Y Y Y N 
MB1208 2 Y 1 Y NT1 N N Y Y Y Y Y Y Y N 
MB1306 2 Y 1 Y IV Y N Y Y Y Y Y Y Y N 
MB1502 2 Y 1 Y VII N N Y Y Y Y Y Y Y N 
MB1567 2 Y 1 Y NT4 N N Y Y Y Y Y Y Y N 
MB1569 2 Y 1 Y IV Y N Y Y Y Y Y Y Y N 
MB1595 2 Y 1 Y IV N Y Y Y ND Y Y Y Y N 
MB1617 2 Y 1 Y IV N Y Y Y Y Y Y Y Y N 
MB1651 2 Y 1 Y IV Y N Y Y Y Y Y Y Y N 
MB1656 2 Y 1 Y III N N Y Y Y Y Y Y Y N 
MB1708 2 Y 1 Y IV N Y Y Y Y Y Y Y Y N 
MB1721 2 Y 1 Y VII N N Y Y ND Y Y Y Y N 
MB1750 2 Y 1 Y IV Y N Y Y Y Y Y Y Y N 
MB1985 2 Y 1 Y ND Y N Y Y ND Y Y Y Y N 
MB2095 2 Y 1 Y IV N Y Y Y Y Y Y Y Y N 
MB247 2 Y 1 Y NT4 N N Y Y Y Y Y Y Y N 
MB323 2 Y 1 Y ND N N Y Y Y Y Y Y Y N 
MB422 2 Y 1 Y NT4 N N Y Y Y Y Y Y Y N 
MB434 2 Y 1 Y NT4 N N Y Y Y Y Y Y Y N 
MB463 2 Y 1 Y IV N Y Y Y Y Y Y Y Y N 
MB466 2 N 1 Y - N N Y Y Y Y Y Y Y N 
MB469 2 N 1 Y - N N Y Y Y Y Y Y Y N 
MB503 2 Y 1 Y IV N Y Y Y Y Y Y Y Y N 
MB546 2 Y 1 Y NT3 N N Y Y Y Y Y Y Y N 
MB551 2 Y 1 Y III N N Y Y Y Y Y Y Y N 
MB591 2 Y 1 Y IV N Y Y Y Y Y Y Y Y N 
MB609 2 Y 1 Y ND N N Y Y Y Y Y Y Y Y 
MB619A 2 Y 1 Y III N N Y Y ND Y Y Y Y N 
 
Table 6. Presence of virulence genes in the isolates. 
 75 
 
M
B
 I
D
 
S
T
 
m
ec
A
 
A
g
r
 
ic
a
 R
A
D
B
C
 
S
C
C
m
ec
  
se
sJ
 
p
ls
 
eb
h
 
A
a
e
 
A
a
p
 
sd
rF
 
se
sC
 
a
lt
E
 
sd
rG
 
S
es
I 
MB918 2 Y 1 Y VII N N Y Y Y Y Y Y Y N 
MB931 2 Y 1 Y III N N Y Y Y Y Y Y Y N 
MB941 2 Y 1 Y VII N N Y Y Y Y Y Y Y N 
MB1335 6 Y 2 N IV N N Y Y Y Y Y Y Y N 
MB1464 6 Y 1 N IV N N Y Y ND Y Y Y Y N 
MB496 6 N 1 Y - N N Y Y N N Y Y Y N 
MB939 6 Y 2 N IV N N Y Y Y Y Y Y Y N 
MB101 7 N 1 Y - N N Y Y Y N Y Y Y N 
MB539 7 N 1 Y - N N Y Y Y N Y Y Y N 
MB1182 16 N 1 Y - N N Y Y Y N Y Y Y N 
MB1230 16 N 1 Y - N N Y Y Y N Y Y Y N 
MB1849 16 Y 1 Y NT1 N N Y Y N N Y Y Y N 
MB601D 16 Y 1 Y IV N N Y Y Y N Y Y Y N 
MB888A 16 Y 1 Y ND N N Y Y Y N Y Y Y N 
MB1229 20 Y 1 Y NT1 N N Y Y Y Y Y Y Y N 
MB2050A 20 N ND ND - N N Y Y ND Y Y Y Y N 
MB995 20 N 1 Y - N N Y Y Y Y Y Y Y N 
MB1091 22 Y 1 Y III N N Y Y Y Y Y Y Y N 
MB1619 22 Y 1 Y III N N Y Y ND Y Y Y Y N 
MB724 22 N 3 Y - N N Y Y N Y Y Y Y N 
MB927 22 Y 1 Y III N N Y Y Y Y Y Y Y N 
MB947 22 Y 1 Y III N N Y Y ND Y Y Y Y N 
MB123 23 Y 1 Y ND N N Y Y N N Y Y Y N 
MB1915 23 N 1 Y - N Y Y Y N N Y Y Y N 
MB775 35 Y 1 Y NT1 N N Y Y Y N Y Y Y N 
MB1299 57 N 2 N - Y N Y Y Y Y Y Y Y N 
MB1421 59 N 3 N - N N Y Y Y Y Y Y Y N 
MB1910 59 Y 1 N IV N N Y Y ND Y Y Y Y N 
MB283 59 Y 1 N ND N Y Y Y Y Y Y Y Y N 
MB585B 59 Y 1 N IV N N Y Y Y Y Y Y Y N 
MB536 69 Y 2 Y IV N N Y Y ND Y Y Y Y N 
MB714 69 Y 2 Y NT5 N N Y Y Y Y Y Y Y N 
 
Table 6. Continued 
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MB906 69 Y 2 Y IV N N Y Y Y Y Y Y Y N 
MB113 72 N 1 Y - N N Y Y N N Y Y Y N 
MB192 73 N 3 N - N N Y Y Y Y Y Y Y N 
MB037 83 Y 1 Y IV N N Y Y Y Y Y Y Y N 
MB1082 83 Y 1 Y IV N N Y Y Y Y Y Y Y N 
MB1298 83 Y 1 Y IV N N Y Y Y Y Y Y Y N 
MB1546 83 Y 1 Y IV N N Y Y Y Y Y Y Y N 
MB1547 83 Y 1 Y IV N N Y Y Y Y Y Y Y N 
MB1568 83 Y 1 Y IV N N Y Y Y Y Y Y Y N 
MB1675 83 Y 1 Y IV N N Y Y Y Y Y Y Y N 
MB1825 83 Y 1 Y IV N N Y Y Y Y Y Y Y N 
MB1956 83 Y ND  ND N N Y Y ND Y Y Y Y N 
MB268 83 Y 1 Y IV N N Y Y Y Y Y Y Y N 
MB449 83 N 1 Y - N N Y Y Y Y Y Y Y N 
MB539A 83 Y 1 Y IV  N N Y Y Y Y Y Y Y N 
MB56 83 Y 1 Y IV N N Y Y Y Y Y Y Y N 
MB599 83 Y 1 Y IV N N Y Y Y Y Y Y Y N 
MB821 83 Y 1 Y IV N N Y Y ND Y Y Y Y N 
MB899 83 Y 1 Y IV N N Y Y Y Y Y Y Y N 
MB999 83 Y 1 Y IV N N Y Y Y Y Y Y Y N 
MB2013 87 Y 2 N IV N N Y Y N Y Y Y Y N 
MB1043 88 Y 3 N IV N N Y ND Y Y Y Y Y N 
MB1260 89 N 1 N - N N Y Y Y N Y Y Y N 
MB1609 89 N 1 N - N N Y Y Y N Y Y Y N 
MB1364 130 Y 1 N ND N N Y Y N Y Y Y Y N 
MB316 130 Y 1 Y IV N N Y Y N Y Y Y Y N 
MB445 130 Y 1 N IV N N Y Y N Y Y Y Y N 
MB415 173 N 2 Y - N N Y Y Y Y Y Y Y N 
MB1457 190 Y 1 Y ND N N Y Y ND Y Y Y ND N 
MB1812 203 N 1 N - N N Y Y N Y Y Y Y N 
MB1143 210 Y 1 N ND Y N Y Y N Y Y Y Y N 
MB1586 210 Y 1 N ND Y N Y Y N Y Y Y Y N 
 
Table 6. Continued 
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MB1709 210 N 1 N - Y N Y Y N Y Y Y Y N 
MB1715 210 N 1 N - Y N Y Y N Y Y Y Y N 
MB1907 210 Y 1 N VII Y N Y Y N Y Y Y Y N 
MB526 210 Y 1 N VII Y N ND Y N Y Y Y Y N 
MB567 218 N 3 N - Y N Y Y Y N Y Y Y N 
MB312 228 N 3 N - N N Y Y Y Y Y Y Y N 
MB1830 329 N 3 N - N N Y Y N N Y Y Y N 
MB429 520 N 1 N - N N Y Y Y N Y Y Y N 
MB1872 540 N 1 N - N N Y Y N N Y Y Y N 
MB1772 5 Y 2 N IV N N Y Y Y Y Y Y Y N 
MB896 5 Y 2 N IV Y N Y Y Y Y Y Y Y N 
MB1057 5-A Y 2 N IV N N Y Y Y Y Y Y Y N 
MB1096B 5-A Y 2 N IV N N Y Y Y Y Y Y Y N 
MB1191 5-A Y 2 N IV N N Y Y Y Y Y Y Y N 
MB1193 5-A Y 2 N IV N N Y Y Y Y Y Y Y N 
MB1226 5-A Y 2 N IV N N Y Y Y Y Y Y Y N 
MB1278 5-A Y 2 N IV N N Y Y Y Y Y Y Y N 
MB1427 5-A Y 2 N IV N N Y Y Y Y Y Y Y N 
MB151C 5-A Y 2 N IV N N Y Y Y Y Y Y Y N 
MB1593 5-A Y 2 N IV N N Y Y Y Y Y Y Y N 
MB1669 5-A Y 2 N IV N N Y Y Y Y Y Y Y N 
MB1769 5-A Y 2 N IV N N Y Y ND Y Y Y Y N 
MB1851 5-A Y 2 N IV N N Y Y Y Y Y Y Y N 
MB1871A 5-A Y 2 N IV N N Y Y Y Y Y Y Y N 
MB1999 5-A Y 2 N IV N N Y Y Y Y Y Y Y N 
MB2033 5-A Y 2 N IV N N Y Y Y Y Y Y Y N 
MB2126 5-A Y 2 N IV N N Y Y Y Y Y Y Y N 
MB2177A 5-A Y 2 N IV N N Y Y Y Y Y Y Y N 
MB746 5-A Y 2 N IV N N Y Y Y Y Y Y Y N 
MB806 5-A Y 2 N IV N N Y Y Y Y Y Y Y N 
MB929 5-A Y 2 N IV N N Y Y Y Y Y Y Y N 
 
Table 6. Continued 
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MB951 5-A Y 2 N IV N N Y Y Y Y Y Y Y N 
MB10 5-B Y 2 N IV Y N Y Y Y Y Y Y Y N 
MB1034 5-B Y 2 N IV N N Y Y Y Y Y Y Y N 
MB1037 5-B Y 2 N IV Y N Y Y Y Y Y Y Y N 
MB1064 5-B Y 2 N IV Y N Y Y Y Y Y Y Y N 
MB108 5-B Y 2 N IV N N Y Y Y Y Y Y Y N 
MB1211 5-B Y 2 N IV N N Y Y Y Y Y Y Y N 
MB1218 5-B Y 2 N IV N N Y Y ND Y Y Y ND N 
MB1312 5-B Y 2 N IV Y N Y Y Y Y Y Y Y N 
MB1347 5-B Y 2 N IV N N Y Y Y Y Y Y Y N 
MB1368 5-B Y 2 N IV N N Y Y Y Y Y Y Y N 
MB1489 5-B Y 2 N IV Y N Y Y Y Y Y Y Y N 
MB149 5-B Y 2 N IV N N Y Y Y Y Y Y Y N 
MB1532 5-B Y 2 N IV N N Y Y Y Y Y Y Y N 
MB1542 5-B Y 2 N IV N N Y Y Y Y Y Y Y N 
MB1679 5-B Y 2 N IV Y N Y Y Y Y Y Y Y Y 
MB1691
A 
5-B Y 2 N IV Y N Y Y Y Y Y Y Y Y 
MB1695 5-B Y 2 N IV Y N Y Y Y Y Y Y Y Y 
MB1961 5-B Y 2 N ND Y N Y Y Y Y Y Y Y N 
MB1962 5-B Y 2 N IV N N Y Y ND Y Y Y ND N 
MB198B 5-B Y 2 N IV N N Y Y Y Y Y Y Y N 
MB2193 5-B Y 2 N IV Y N Y Y Y Y Y Y Y N 
MB227A 5-B Y 2 N NT2 N N Y Y Y Y Y Y Y N 
MB383 5-B Y 1 N IV Y N Y Y Y Y Y Y Y N 
MB396 5-B Y 2 N NT2 N N Y Y Y Y Y Y Y N 
MB492 5-B Y 2 N NT2 N N Y Y Y Y Y Y Y N 
MB524 5-B Y 2 N IV N N Y Y Y Y Y Y Y N 
MB606 5-B Y 2 N IV N N Y Y Y Y Y Y Y N 
MB634 5-B Y 2 N IV N N Y Y Y Y Y Y Y N 
MB716 5-B Y 2 N NT2 N N Y Y Y Y Y Y Y N 
MB740 5-B Y 2 N IV Y N Y Y Y Y Y Y Y N 
MB860 5-B Y 2 N IV N N Y Y Y Y Y Y Y N 
 
Table 6. Continued 
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MB883 5-B Y 2 N NT2 N N Y Y Y Y Y Y Y N 
MB905 5-B Y 2 N NT2 Y N Y Y Y Y Y Y Y N 
MB972 5-B Y 2 N IV Y N Y Y Y Y Y Y Y N 
MB988 5-B Y 2 N IV Y N Y Y Y Y Y Y Y N 
MB182 ND Y 1 N IV N Y N Y N N Y Y Y N 
MB1908 ND N 3 N - N N N Y N N Y Y Y N 
MB1935 ND N 3 N - N N ND Y N N Y Y Y N 
MB255 ND N 3 N - N N Y Y N N Y Y Y N 
MB339 ND N 3 N - N N Y Y N N Y Y Y N 
MB446 ND Y 2 N NT1 N N Y Y Y Y Y Y Y N 
MB497 ND N 2 Y - N N ND Y N Y Y Y Y N 
MB89 ND Y ND Y NT1 N N Y Y ND Y Y Y Y N 
MB895 ND N 2 N - N N Y Y N N Y Y Y N 
NT1 represents a pseudo SCC element containing the mec gene complex but lacking the 
ccr genes 
NT2 represents a SCCmec Type IV element with an additional ccrC8 enzyme gene.  
NT3 represents a SCCmec Type VII element with an additional ccrA4B4 gene complex. 
NT4 represents a SCCmec Type VII element with an additional ccrA4B5 gene complex. 
NT5 represents a SCCmec Type IV element with an additional ccrC2 enzyme gene. 
ND stands for could not be determined.  
 
Table 6. Continued 
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Results 
 
Epidemiology study  
We retrospectively collected 171 clinical isolates obtained from blood samples of cancer 
patients at MD Anderson hospital, Houston, Texas. 30 different ST and 9 isolates with 
unknown ST were identified in the collection (Table 6). ST 2, ST 5 and ST83 accounted 
for 64% of the total isolates. 58 of the isolates corresponded to ST5 (34%), 34 of the 
isolates corresponded to ST 2 (20%) and 17 isolates were identified as ST83 (10%). 6 of 
the isolates belonged to ST210. 16 of the STs were singletons, while ST6, ST7, ST16, 
ST20, ST22, ST23, ST59, ST69, ST89 and ST130 were each represented by 2-5 isolates. 
STs were grouped into two clonal complexes CC2 and CC5. In this study, CC2 
comprised of founder ST2, ST22, ST 35 and ST16. CC5 comprised of founder ST5, 
ST6, ST130, ST210, ST7, ST190, ST87, ST59, ST1005, ST89 and ST88.  
 
The sesJ gene is present in 30/171 (18%) of these isolates. This data is consistent with 
the previously reported epidemiology study performed using the blood isolates from 
patients with infected left ventricular assist drivelines [201]. The sesJ gene was detected 
in 6/34 of ST2 isolates (18%), 16/58 of ST5 isolates (26%) and 6/6 of ST210 isolates  
(100%) (Table 7). 2/16 singelton ST were also positive for sesJ gene. Additionally, we 
identified the pls gene in 10/ 171 (6%) isolates. 7/34 (21%) of ST2, 1/4 (25%) of ST59  
and 1/2 of ST23 were identified as pls+ isolates (Table 7). The sesJ and pls gene did not 
occur together in any of the isolates (Table 6). Both the sesJ gene and the pls gene are 
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ST Number 
of 
isolates 
sesJ+ 
isolates 
(percentage) 
pls+ 
 
isolates 
(percentage) 
ST 2 34 6 (18) 7(21%) 
ST 83 17 0 0 
ST 210 6 6 (100) 0 
ST 5 58 16 (28) 0 
ST23 2 0 1 
ST59 4 0 1 
Others 25 0 0 
Singeltons 16 2 0 
Unknown 9 0 1 
Total 171 30 (17.5) 10 (6%) 
 
Table 7. Presence of the sesJ and the pls gene in different ST. 
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present in selective ST which points towards genetic differences in the STs. 
 
Distribution of MRSE and MSSE isolates  
Isolates analyzed in this study included 139 (81%) MRSE isolates and 32 (19%) MSSE 
isolates. 32 MSSE isolates were distributed in over 20 different STs. However, ST2, 
ST5, ST83 i.e. STs with the most number of isolates, together comprised only 4 MSSE 
isolates (Table 6). The sesJ gene was present in 26/139 MRSE (19%) isolates and 4/32 
MSSE (13%) isolates (Table 8). Out of 4 sesJ+ MSSE isolates, 2 isolates belong to 
ST210, and other 2 isolates were singletons ST218 and ST57. Thus, the sesJ gene is 
present in both MRSE and MSSE isolates, with no preference for either one. On the 
other hand, the pls gene is present in the MRSE isolates only (Table 6 and 8).  
 
Presence of virulence genes 
The presence of S. epidermidis virulence related genes was tested in the isolate 
collection, which revealed ST related patterns (Table 6). For example, ST2 and ST83 
isolates in this study encode for ica operon genes while ST210 and ST5 isolates do not. 
The agr quorum sensing system in S. epidermidis controls biofilm formation by 
regulating secreted protease production. ST2, ST83, ST210 isolates in the collection 
contain agr Type 1 genes whereas ST5 isolates (except for one) contain agr Type II 
genes. The agr type III genes were least represented in the collection. Ebh, SdrG, Aae, 
AltE, SesC, SdrF, Aap have all been shown to play a role in biofilm formation. At least 
97% of the isolates contained the ebh, sdrG, aae, altE and sesC genes. 147/171 (86%) 
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 Number of 
isolates 
sesJ + isolates (percentage) pls+ isolates (percentage) 
MRSE 139 26(19) 10 (7) 
MSSE 32 4(13) 0(0) 
 
Table 8. Presence of the sesJ and pls gene in MRSE and MSSE isolates. 
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isolates contained the sdrF gene. 128/171 (75%) isolates were confirmed positive for the 
aap gene. Only 4 isolates encoded the sesI gene. Interestingly, all ST210 isolates contain 
the sesJ gene but not icaADBC and aap genes. In conclusion, presence or absence of 
certain genes correlated with the ST.  
 
Distribution of SCCmec amongst the isolates 
SCCmec types were assigned to 105 of 139 isolates while 33 isolates had untypeable 
SCCmec elements (Table 6). One isolate contained both the SCCmec element Type IV 
and Type VII. Out of XI SCCmec types, the isolate collection contained SCCmec Type 
III, Type IV and Type VII. 91 of 139 (65%) of MRSE isolates harbored SCCmec Type 
IV, followed by 8 (6%) isolates contained Type III and 6 (4%) isolated were assigned 
SCCmec Type VII. Amongst the untypeable isolates, 14 isolates had a combination of 
typeable SCCmec and additional ccr enzyme complex. Furthermore, 7 of the untypeable 
isolates had pseudo-SCCmec elements which lacked ccr genes. No other SCCmec types 
were detected. 
 
SCCmec Type IV was present in a wide range of STs: ST2, ST83, ST59, ST69, ST130, 
ST6, ST16, and ST5. SCCmec Type III was harbored in ST2 and ST22 isolates. 
Additionally, SCCmec Type VII was represented in ST2 and ST210. ST2 had the most 
diversity in SCCmec with Type IV, Type VII, Type III, combination of two SCCmec, 
pseudo elements and SCCmec elements with the additional ccr enzyme complex. All 
SCCmec Type IV ST2 isolates either contained the sesJ gene or the pls gene. Whereas, 
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ST5 isolates harbored either Type IV or SCCmec elements with Type IV and additional 
ccr enzyme complex, and ST83 had only Type IV. As reported before, ST2 has a high 
recombination frequency, which is also evident here with the diversity of SCCmec 
elements.  
 
SesJ and Pls are present in SCCmec elements 
The sesJ and pls genes are both present in mobile genetic elements called SCCmec 
elements. In this study, MRSE blood isolates obtained from cancer patients encode the 
sesJ gene in SCCmec Type IV, Type VII and novel SCCmec elements containing 
additional ccr genes. Previous reports have shown that the pls gene is present in SCCmec 
Type I element [199, 200]. Whereas, in this collection the pls gene is only present in 
SCCmec Type IV element (Table 6).   
 
The NCBI database search yielded in 4 sesJ+ S. epidermidis isolates. S. epidermidis 
NIH06004 and S. epidermidis NIH04003 isolates were collected from blood of cancer 
patients with an infected catheter. S. epidermidis NIH051475 was collected from an 
infected joint of a patient with myelodysplastic syndrome. Lastly, S. epidermidis 
NIHLM039 was obtained from the retro auricular crease of a healthy individual.  S. 
epidermidis NIH06004, NIH04003 and NIH051475 are methicillin resistant and encode 
the sesJ gene in the composite SCCmec elements containing remnants of SCCmec Type 
IV (Figure 15). Although S. epidermidis NIHLM039 lacks the mecA gene, it has other 
characteristic features of the SCC element i.e. the ccr gene, direct repeats and insertion          
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Figure 15. The sesJ gene is located in composite SCCmec element. Red flags represent presence of direct repeats.  
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ST2        PEVDSEVLDNSKQGTDNDNSSNHSEDNIVTYAEPTALTNTRSVDSPSRVSSDNSQAQKQG 
ST57       PEVDSEVLDNSKQGTDNDNSSNHSEDNIVTYAEPTALTNTRSVDSPSRVSSDNSQAQKQG 
ST218      PEVDSEVLDNSKQGTDNDNSSNHSEDNIVTYAEPTALTNTRSVDSPSRVSSDNSQAQKQG 
ST5        PEVDSEVLDNSKQGTDNDNSSNHSEDNIVTYAEPTALTNTRSVDSPSRVSSDNSQAQKQG 
ST210      PEVDSEVLDNSKQGTDNDNSSNHSEDNIVTYAEPTALTNTRSVDSPSRVSSDNSQAQKQG 
           ************************************************************ 
 
ST2        KNVNDSIKVNSVDTDKEYVEPNNGQGFSTNVSFEVDGKVNKGDYFTVDMPEYADFNGIAD 
ST57       KNVNDSIKVNSVDTDKEYVEPNNGQGFSTNVSFEVDGKVNKGDYFTVDMPEYADFNGIAD 
ST218      KNVNDSIKVNSVDTDKEYVEPNNGQGFSTNVSFEVDGKVNKGDYFTVDMPEYADFNGIAD 
ST5        KNVNDSIKVNSVDTDKEYVEPNNGQGFSTNVSFEVDGKVNKGDYFTVDMPEYADFNGIAD 
ST210      KNVNDSIKVNSVDTDKEYVEPNNGQGFSTNVSFEVDGKVNKGDYFTVDMPEYADFNGIAD 
           ************************************************************ 
 
ST2        YKAANNKIYPTINDGEQVVANGVYDTETKKLVYTFTDYVNKKDNIKGQFEIPQFIDRKNA 
ST57       YKAANNKIYPTINDGEQVVANGVYDTETKKLVYTFTDYVNKKDNIKGQFEIPQFIDRKNA 
ST218      YKAANNKIYPTINDGEQVVANGVYDTETKKLVYTFTDYVNKKDNIKGQFEIPQFIDRKNA 
ST5        YKAANNKIYPTINDGEQVVANGVYDTETKKLVYTFTDYVNKKDNIKGQFEIPQFIDRKNA 
ST210      YKAANNKIYPTINDGEQVVANGVYDTETKKLVYTFTDYVNKKDNIKGQFEIPQFIDRKNA 
           ************************************************************ 
 
ST2        KTSGDYDLNYNIADKTVSKPMKIVYNNYDEGHVVANTSSLITKADLFNVGSHDYTQYIYV 
ST57       KTSGDYDLNYNIADKTVSKPMKIVYNNYDEGHVVANTSSLITKADLFNVGSHDYTQYIYV 
ST218      KTSGDYDLNYNIADKTVSKPMKIVYNNYDEGHVVANTSSLITKADLFNVGSHDYTQYIYV 
ST5        KTSGDYDLNYNIADKTVSKPMKIVYNNYDEGHVVANTSSLITKADLFNVGSHDYTQYIYV 
ST210      KTSGDYDLNYNIADKTVSKPMKIVYNNYDEGHVVANTSSLITKADLFNVGSHDYTQYIYV 
           ************************************************************ 
 
ST2        NPKSEDSYNTRLTIQGYQEDVNDSSTLLNPDDTKIEILDAKSSDNIVPSFHINDEDFEDV 
ST57       NPKSEDSYNTRLTIQGYQEDVNDSSTLLNPDDTKIEILDAKSSDNIVPSFHINDEDFEDV 
ST218      NPKSEDSYNTRLTIQGYQEDVNDSSTLLNPDDTKIEILDAKSSDNIVPSFHINDEDFEDV 
ST5        NPKSEDSYNTRLTIQGYQEDLNNSSTLLNPKDSNIEILDAKSSDNITPSFYVNDSDFENV 
ST210      NPKSEDSYNTRLTIQGYQEDLNNSSTLLNPKDSNIEILDAKSSDNITPSFYVNDSDFENV 
           ********************:*:*******.*::************.***::**.***:* 
 
ST2        TGNFGINQKGDKKAQIDFGHIDHPYIVKVTSKIDPSSSQDLRTRVIMENENAEGTTDFYA 
ST57       TGNFGINQKGDKKAQIDFGHIDHPYIVKVTSKIDPSSSQDLRTRVIMENENAEGTTDFYA 
ST218      TGNFGINQKGDKKAQIDFGHIDHPYIVKVTSKIDPSSSQDLRTRVIMENENAEGTTDFYA 
ST5        TNQYKIDQIGDKKAQIDFGHIDHPYIVKVTSKIDPNSSKDLRTRVIMENENAEGTKDFYV 
ST210      TNQYKIDQIGDKKAQIDFGHIDHPYIVKVTSKIDPNSSKDLRTRVIMENENAEGTKDFYV 
           *.:: *:* **************************.**:****************.***. 
 
ST2        HDNTVERLGANGVATGNE 
ST57       HDNTVERLGANGVATGNE 
ST218      HDNTVERLGANGVATGNE 
ST5        HDNTVERLGANGVATGNE 
ST210      HDNTVERLGANGVATGNE 
           ****************** 
 
 
Figure 16. Sequence comparison of SesJ A-region from different STs.  ST2, ST57, 
ST218 isolates contain SesJ isoform I. ST5 and ST210 isolates contain SesJ isoform II.  
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in the orfX gene (Figure 15). In S. epidermidis NIHLM039 the sesJ gene is located on 
SCC non-mec element.  
 
SesJ isoforms 
Most MSCRAMMs have isoforms, which are identified based on the sequence 
difference in the A-region. For example, FnBPA has seven isoforms based on the A-
region itself [213]. Within the A-region, most of the differences lie in the N3 region of 
the MSCRAMMs. Similarly, two different isoforms of SesJ were observed in the thirty 
sesJ+ isolates in the collection. SesJ A-region from the two isoforms, share 94.7% 
identity with each other, with most differences in the N3 region (Figure 16) [201].  It is 
worth noting, that SesJ isoforms are present in different clonal complex, independent of 
SCCmec carrying the sesJ gene. Both ST5 and ST210 both represent CC5 and encoded 
SesJ isoform II but ST5 sesJ+ isolates harbored SCCmec Type IV and ST210 isolates 
harbored SCCmec Type VII. On the other hand, ST2 (CC2) sesJ+ isolate contained SesJ 
isoform I even though these isolates also harbored SCCmec Type IV (Table 9).  
 
Increase in SesJ frequency  
171 collected isolates were collected from July, 2014 to May, 2016 at MD Anderson 
hospital. We grouped the isolates into 3 groups based on the date of isolation. 54 isolates 
used in this study were collected in year 1, 54 isolates in year 2 and 62 isolates in year 3. 
Frequency of the sesJ gene in these isolates rose from 7% in year 1 to 18% in year 2 and 
24% in year 3. On the other hand, frequency of the pls gene in year 1 was 9%, and 0% in  
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ST CC sesJ+/total isolates  Isoform SCCmec Type 
ST 2 2 6/34 I IV 
ST 5 5 16/58 II IV 
ST 210 5 6/6 II VII 
 
Table 9. SesJ isoforms are present in different clonal complexes. 
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year 2, followed by 6% in year 3 (Figure 17). Thus, the frequency of sesJ+ S. epidermidis 
isolates has increased three times in three years. This increase was specific to SesJ and 
not observed for Pls. 
 
Discussion  
 
S. epidermidis has an open pan genome perhaps because of the high frequency of genetic 
recombination [109]. Accessory genes constitute 20% of the whole genome in S. 
epidermidis [109].  In present work, two of the accessory genes encoding for cell wall 
anchored proteins, present in SCCmec elements were identified.  SesJ is present in 
SCCmec Type IV, VII and non-typeable elements.  In MSSE, the sesJ gene is present in 
a SCC non-mec element containing the ccr genes. Although origin of the sesJ gene is not 
known, it’s speculated that given the chimeric nature of the protein it was generated 
through recombination in CoNS. Additionally, we identified the pls gene in SCCmec 
Type IV. Pls has been reported before in SCCmec Type 1 and ψSCCpls [203, 214] in S. 
aureus. CoNS also acts as a reservoir of virulence factors that can be transferred through 
horizontal gene transfer to other species like S. aureus [150]. Presence of the sesJ gene 
in SCCmec elements raises the possibility of transfer of the gene to S. aureus.  
 
A high degree of genetic diversity was observed in the isolates used in this study. This is 
consistent with previously reported studies.  ST5, ST2 and ST83 accounted for over 60% 
of the total isolates tested. ST2 is one of the most successful genetic lineages of  
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Figure 17. Frequency of the sesJ+ S. epidermidis isolates is increasing. 
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S. epidermidis spread worldwide [50, 181, 183, 215-217]. Recent reports have 
documented higher proportion of ST5 in their studies compared to ST2 [50, 217, 218]. 
Similarly, ST5 clinical isolates predominated in this study. The sequence type ST83 is 
not as widespread and predominant as ST2 and ST5 but ST83 has been observed in the 
US, Italy and Greece [50, 136, 219]. We also observed ST210 in our clinical isolates 
obtained from patients. In another study, ST210 was associated with healthcare 
personnel only and absent in isolates obtained from patients [215]. Interestingly, all  
ST210 isolates in our study encode the sesJ gene. Perhaps, S. epidermidis ST210 isolates 
can cause infection upon acquiring potential virulence factors like SesJ.  
 
Although this study is limited to one hospital in the US, we reported previously on 
an epidemiology study for the sesJ gene in isolates collected at Columbia 
University Medical Center [201]. Thus, the sesJ gene is not confined to one hospital. In 
a previous study, we investigated isolates from patients with infected left ventricular 
assist driveline. This study focused on blood isolates from cancer patients at MD 
Anderson hospital. We observed a similar percentage of sesJ+ isolates in both studies. 
Presence of the sesJ gene in clinical isolates from different patients and geographic 
location shows that sesJ+ isolates are prevalent in the US. 
 
Both SesJ and Pls are located in multiple SCCmec elements. SesJ is the first 
MSCRAMM encoded on a mobile genetic element. It is also worth noting that (i) SesJ is 
present in MSSE isolates and (ii) in MSSE isolates, the sesJ gene is located in SCC non-
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mec element. In our two studies, we observed the sesJ gene in commensal isolates 
although its frequency in commensal isolates from healthy individuals is not known. It 
was surprising that Pls was only present in MRSE isolates unlike SesJ. Virulence factors 
like SrdG, ica operon, Aap and more, are present in both commensal and infectious 
isolates. We hypothesize that virulence factors required for establishing infection are 
also required for the commensal lifestyle of the bacteria.  
 
In this collection, we observed two isoforms of SesJ with 95% identity in the A-region. 
The A-region is the ligand binding region of the MSCRAMM that evolves through point 
mutations. Multiple isoforms of other well-studied MSCRAMMs have been identified, 
with studies underway to understand the differences in the molecular interaction of the 
isoform with the ligand [213, 220]. The two isoforms of SesJ are present in different 
clonal complex, which is consistent with S. aureus MSCRAMMs (unpublished 
observation from the lab).  
 
Interestingly, in three years the frequency of SesJ increased 3 fold. This increase was 
specific to SesJ as the frequency of the pls gene in the same collection and similar 
SCCmec element did not increase over the 3 year period. Increase in the sesJ gene 
frequency does not correlate with number of isolates obtained in the respective years or 
with the number of MRSE isolates alone obtained during the time period. The sesJ gene 
probably utilizes Ccr enzymes to move around. Increase in the frequency of SesJ 
suggests that SesJ provides a unique advantage to S. epidermidis. Pls plays a role in 
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biofilm formation by utilizing G5 repeats i.e. a similar mechanism as Aap. Unlike S. 
aureus, S. epidermidis does not encode as many virulence factors with repetitive or 
redundant functions. SesJ potentially provides a unique advantage to S. epidermidis, 
which has contributed to its increase in frequency over Pls.  Further studies are 
warranted to uncover the role of SesJ in S. epidermidis pathogenesis.  
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CHAPTER IV 
CONCLUSIONS 
 
S. epidermidis does not possess a large arsenal of virulence factors compared to S. 
aureus. Unlike S. aureus, S. epidermidis causes low grade but persistent infections that 
are hard to treat. Most clinical isolates of S. epidermidis carry multi drug resistance, 
which limits the antibiotics available to the patient.  Biofilm matrix produced by S. 
epidermidis isolates creates a barrier for the antibiotics to target the embedded cells. In 
addition, antibiotics target live bacterial cells whereas biofilm also contains 
metabolically inactive bacterial cells that are resistant to antibiotics. Thus, these features 
make it challenging to treat S. epidermidis infections.  In the past two decades, the 
identity and mechanism of action of some of the S. epidermidis virulence factors have 
been discovered but there is still a big gap in understanding how S. epidermidis causes 
infections. Furthermore, most of the characterized virulence factors are encoded in the 
core genome, whereas 20% of the S. epidermidis genome consists of variable genes 
which can alter the pathogenic potential of the isolate [109]. Therefore, a better 
understanding of the S. epidermidis virulence factors and their role in establishing 
infection will help identify potential drug targets. The development of new drugs that 
function by blocking the interaction of the virulence factor with the host ligand provides 
an alternative to conventional antibiotics.  
 
Studies described in this thesis revealed two, previously unidentified, potential virulence  
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factors of S. epidermidis encoded on a MGE: SesJ and Pls. SesJ is a chimeric cell wall 
anchored protein that is expressed on the surface of S. epidermidis. SesJ is also a 
prototype of a novel NTR containing subfamily of MSCRAMM. SesJ contains 
conserved features of an MSCRAMM as well as regions like the NTR and ACR, which 
have not been found in MSCRAMM before. The NTR-region is present after the signal 
sequence and contains a repeated 15 amino acid motif. There are the only two other S. 
epidermidis CWA proteins known to contain NTRs i.e. Aap and Pls. The A-region of 
SesJ has characteristic features found in MSCRAMMs; it contains a two tandem IgG-
like fold containing the trench motif and the latch region. MSCRAMMs bind to their 
ligands using the DLL mechanism. The presence of unique characteristics of 
MSCRAMM in SesJ indicates that the protein potentially binds to its ligand using the 
DLL mechanism. SesJ also contains two B-repeats similar to the B-repeats in the Sdr 
sub-family of MSCRAMMS. In addition, the ACR region is present near the C-terminus 
and contains 20 amino acid long repeat motif similar to serine rich region of SRRPs 
from Streptococcus. At the C-terminus SesJ contains LPXTG motif, transmembrane 
domain and a small cytoplasmic tail similar to other known MSCRAMMs.  
 
Three structural homologs of SesJ were also identified in other coagulase negative 
staphylococci species. SesJ structural homologs ScsJ, ShsJ and SdrI proteins are present 
in S. capitis, S. haemolyticus and S. saprophyticus, respectively. SesJ and its structural 
homologs have identical domain organization as well as characteristics unique to 
MSCRAMMS. Like SesJ, the structural homologs also contain N-terminal signal 
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sequence, the NTR region, A-region, two B-repeats each, ACR region, LPXTG motif, 
transmembrane domain and a short cytoplasmic tail. Similar to the SesJ protein, N2N3 
region of ScsJ, ShsJ and SdrI proteins also comprise of two linked IgG-like fold 
containing a predicted latch sequence and the trench motif. Together these proteins form 
the NTR containing sub-family of MSCRAMMs present in coagulase negative 
staphylococci.  
 
Although SesJ, ScsJ, ShsJ and SdrI are structurally similar, the A-region of SesJ and its 
structural homologs have amino acid sequence identities as low as 30%, indicating that 
these proteins most likely bind to different ligands. For example, SdrI has been shown to 
bind to fibronectin while my preliminary experiments revealed that SesJ does not 
interact with fibronectin. The function of SesJ, ScsJ and ShsJ is not known. Along with 
the MSCRAMM features, the NTR regions of all these proteins also share a conserved 
motif. Even though the function of the NTRs is not known, the conserved motif suggests 
a shared function amongst these proteins.  
 
Next, epidemiology studies revealed that the sesJ gene is present in ~18% of the clinical 
isolates tested. In these studies, blood isolates from patients with infected left ventricular 
assist devices, cancer patients with bloodstream infections, and colonizing isolates from 
HIV infected patients were used. The sesJ gene is present in all the different types of 
clinical isolates tested, suggesting a broader potential role in the bacterial pathogenesis. 
Unlike S. aureus that is only found in 30% of the population, S. epidermidis is 
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ubiquitous on human skin. It is therefore not surprising that S. epidermidis encodes 
factors required in both commensal and pathogenic lifestyle. These virulence factors 
could help the bacteria maintain a commensal lifestyle but when given an opportunity 
also act as virulence factors required in infection [28]. This is evident with the sdrG, 
sdrF, icaADBC, aap genes which are present in both commensal and bloodstream 
isolates. Likewise, the sesJ gene is present in both commensal and bloodstream isolates. 
 
Additionally, the sesJ gene is encoded on a composite SCCmec Type IV, Type VII and 
non typeable elements. In methicillin sensitive isolates, the sesJ gene is present in a 
ψSCC element containing the ccr genes but missing the mec gene complex. SesJ is the 
first MSCRAMM known to be encoded on a mobile genetic element. All other known 
MSCRAMMs belonging to Sdr-Clf, Fnbs and Cna family are encoded within the core 
genome. The presence of the sesJ gene in a MGE explains the low frequency of the gene 
in clinical isolates compared to other staphylococcal MSCRAMMS.  The methicillin 
resistance gene is acquired by the bacteria under antibiotic pressure. The sesJ gene most 
likely hitchhikes with the mec and ccr gene complex and is acquired by the neighboring 
bacteria. Interestingly, the frequency of sesJ+ isolates has increased 3 fold in only 3 years 
at MD Anderson. Antibiotic pressure and presence of the sesJ gene in a MGE has most 
likely contributed to its increase in frequency.  
 
Pls, another cell wall anchored protein, was identified in a SCCmec Type IV in this 
study. At the N-terminal of the Pls protein is the signal sequence, followed by NTR-
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region (similar to that found in SesJ), the A-region, G5 repeats (involved in biofilm 
formation), the SD repeat (as found in Sdr MSCRAMM) and the cell wall anchoring 
region [204]. Previously, the Pls protein has been shown to be associated with SCCmec 
Type I in S. aureus, S. capitis, S. haemolyticus and S. epidermidis, and ψSCC element in 
S. aureus WA MRSA-40 [214]. As suggested by the multiple different types, sub-types 
and multiple novel SCC elements reported in the literature, SCCmec elements are a 
hotspot for recombination [138, 192-195, 221]. It is perhaps the result of recombination 
that the pls gene is also present in SCCmec Type IV element. In S. aureus, Pls protein 
has been reported to play a role in septic arthritis as well as biofilm formation. However, 
it’s role in S. epidermidis pathogenesis has not been studied. It can be assumed that Pls 
plays a role in biofilm formation in S. epidermidis too.  
 
Although, a function of SesJ is not known yet, studies are underway to identify its role 
in S. epidermidis pathogenesis. Compared to S. epidermidis, S. aureus MSCRAMMs are 
well studied and functions are known for most of the MSCRAMMs. Based on the 
previous studies, MSCRAMMs have been shown to play a role in adhesion of the 
bacteria to the host tissue, mediating invasion of the bacteria into host cells, evading 
immune response and biofilm formation. To this end, I tested binding of the SesJ protein 
to known MSCRAMMs ligands including plasma proteins (fibrinogen from mouse, rat, 
rabbit, pig, sheep, bovine, dog and human, fibronectin), extracellular matrix proteins 
(vitronectin, laminin, fibromodulin, cytokeratin 10, decorin core, decorin, biglycan core, 
biglycan, collagen I/II/III/IV) as well as complement proteins (factor I, factor H, factor 
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B, factor D, c1q). SdrG interaction with human protein fibrinogen was used as a positive 
control for the adhesion assays. First, binding of the recombinant SesJ A-region was 
tested in a solid phase assay where potential ligands were immobilized on a polystyrene 
plate. Next, bacterial attachment assays were done utilizing full length SesJ protein 
expressed on the surface of Lactococcus lactis, a heterologous host. Similar to solid 
phase assay, host proteins were immobilized on a polystyrene plate and incubated with 
the L. lacis expressing SdrG or SesJ. L. lactis containing empty vector was used as 
negative control to rule out interaction of L. lactis CWA proteins with the tested host 
proteins. While, positive control SdrG interaction could be observed in these assays, 
SesJ did not interact with any of the proteins tested.  
 
Most MSCRAMMs bind to plasma proteins e.g. ClfA/B, FnbpA/B, Bbp bind to 
fibrinogen present in the plasma, FnbpA/B bind to fibronectin. To avoid immobilizing 
the host proteins on a polystyrene plate, pull down assays were developed to test binding 
of the soluble recombinant SesJ protein with the soluble plasma/serum proteins. First, 
histidine tag system was established for the pull down experiment. However, high 
background was observed in pull down assays with histidine tagged recombinant 
protein. Therefore, Strep-tagged recombinant SesJ AB region was purified and 
streptactin resin was used to capture the strep-tagged protein.  Although interaction of 
the strep tagged FnbpA protein could be observed with fibrinogen and fibronectin in the 
plasma, no interactions were observed for the SesJ protein. These experiments show 
SesJ did not bind to common MSCRAMM ligands like fibrinogen and fibronectin.  
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Although a ligand for recombinant SesJ AB could not be identified with the pull down 
assay, interaction of SesJ with proteins present in low concentration in plasma cannot be 
ruled out. Pull down assays can identify stable or strong interacting ligands present in 
sufficient concentration to show a band on the SDS page gel.  However, weak or 
transient interactions, and strong interactions with proteins present in low concentration 
are often missed by the pull down assays.  Perhaps a broader ligand screening assays like 
phage display can help identify a ligand for the SesJ protein. Phage display system was 
used to identify a ligand for MSCRAMM SdrC, which provides a proof of concept that 
this technology can be used for identifying MSCRAMM ligands [104]. Additionally, 
phage display system does not depend on the concentration of the ligand but is limited 
by the type of library used for the assay, and has a higher false positive rate.  On the 
other hand, it can be hypothesized that the glycosylation of the SesJ protein is required 
for its binding to the ligand. To test this hypothesis, the gftA and gtfB gene, encoded next 
to the sesJ gene in SCCmec cassette can be transformed into the L. lactis expressing full 
length SesJ protein on the surface. The new constructs can be used in a bacterial 
attachment assays.   
 
MSCRAMMs have also been shown to play a role in immune evasion. Cna, S. aureus 
MSCRAMM inhibits classical complement pathway by binding to the collagen like stalk 
of C1q [103]. Similarly Bbp and SdrE proteins interact with Factor H and inhibit 
alternative complement pathway [107]. To test the potential role of SesJ in immune 
evasion, classical complement pathway inhibition as well as phagocytosis inhibition was 
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tested. Inhibition of classical complement pathway was tested by monitoring 
complement mediated hemolysis of antibody sensitized sheep erythrocytes. MSCRAMM 
Cna was used as positive control which has been demonstrated to inhibit classical 
complement pathway. Recombinant Cna and SesJ A-region was incubated with normal 
human serum before addition of the antibody sensitized sheep erythrocytes. The 
inhibition of hemolysis was monitored by measuring the absorbance of the supernatant. 
While, Cna did inhibit hemolysis of sheep erythrocyte, no effect was observed for SesJ.  
 
Phagocytosis inhibition by the SesJ protein was tested using freshly isolated human 
neutrophils from a healthy individual. A secreted S. aureus protein Efb that inhibits 
phagocytosis was used as a positive control. FITC labeled bacteria was mixed with 
either normal human serum or normal human plasma in the presence of recombinant Efb 
or SesJ AB. Next, freshly isolated neutrophils were added to the mixture. Phagocytosis 
was detected using flow cytometry. While Efb demonstrated phagocytosis inhibition as 
expected, SesJ did not cause inhibition. While SesJ did not stimulate an immune evasion 
in the assays tested, possible role of SesJ in immune evasion cannot be completely ruled 
out. Biofilm formation is one of the mechanisms used by S. epidermidis to immune 
evasion. SesJ role in biofilm formation is currently under investigation. Also, S. 
epidermidis causes low grade and persistent infection and most likely evades immune 
response through multiple mechanisms. Moreover, S. aureus has numerous mechanisms 
for immune evasion that have not been yet studied in S. epidermidis. Thus, detailed 
studies are required to discover if and how SesJ plays a role in immune evasion.  
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The role of SesJ in biofilm formation is currently under investigation. In S. aureus, 
MSSA isolates form primarily polysaccharide dependent biofilm whereas MRSA 
isolates form protein dependent biofilm [222]. The quorum sensing system agr is 
regulated differentially in MRSA and MSSA isolates. The agr operon is upregulated in 
MSSA isolates which in turn upregulates PIA and secreted proteases production. 
Secreted proteases cleave the surface protein, resulting in a biofilm formation composed 
of PIA. On the other hand, in MRSA isolates, the agr operon is downregulated, which 
inhibits PIA production and upregulates surface protein expression. Therefore, MRSA 
isolates form a surface protein dependent biofilm formation. The presence of the sesJ 
gene in SCCmec element along with similarities of NTR region of SesJ to biofilm 
forming protein Aap and Pls point to the potential role of SesJ in biofilm formation [180, 
204]. Additionally, MSCRAMMs like FnbpA and SdrC promote biofilm formation 
through homophilic interactions of the N2N3 region. Blood isolates obtained from 
cancer patients presented with blood stream infections will be used for the static biofilm 
formation assays, followed up by biofilm experiments performed under flow to mimic in 
vivo conditions.  
 
These studies have revealed that SesJ has characteristics of a virulence factor and its 
frequency is increasing at MD Anderson. In my study, I observed a 3 fold increase in the 
frequency of the sesJ gene over the 3 year period. The observed increase was specific to 
the SesJ protein and not observed for the Pls protein. This increase did not correlate to 
the total number of isolates collected in a year, number of methicillin resistant isolates 
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collected or to clonal expansion. Increase in the sesJ gene frequency from year 1 – year 
2 was observed because of an increase in the sesJ+ ST 5B isolates whereas, the total 
number of ST5B isolates collected in year 1 and year 2 was similar. Increase in year 2 – 
year 3 was caused by an increase of the sesJ+ ST210 isolates. Increase in the sesJ+ 
isolates at MD Anderson emphasizes the need to discover a ligand for SesJ and its role 
in pathogenesis and will be the focus of future studies. Different isoforms of SesJ may 
bind to the ligand with different affinities and modulate the effect of the interaction in S. 
epidermidis pathogenesis.   
 
It is known that the expression of the mecA operon is increased in the presence of the 
methicillin. Also, MRSA isolates form a protein dependent biofilm. While SesJ is 
constitutively expressed on the surface of S. epidermidis isolate tested, it could be the 
basal level of SesJ expression. It is likely that expression of the SesJ protein increases in 
the presence of methicillin and be regulated by a molecule within the SCCmec cassette. 
Presence of the SesJ protein in SCCmec cassette in a MRSE isolate indicates that SesJ 
plays a role in protein dependent biofilm formation in MRSE isolates. It is plausible that 
the NTR region of SesJ protein plays a role in the attachment phase of the biofilm 
formation and the A-region promotes accumulation phase through homophilic 
interactions. These possible mechanisms will be tested in the biofilm formation assays. 
 
It is worth noting that the SCCmec cassette encodes for Ccr enzymes responsible for the 
insertion and excision of the cassette. Some future studies will also be directed to 
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understand if sesJ and associated genes move around independently or by hijacking the 
Ccr enzymes. In addition, the analysis of clinical outcome data from cancer patients will 
help understand whether the presence or absence of the sesJ /pls gene correlate with 
clinical outcome in patients. From my analysis I can conclude that the sesJ gene is 
present in multiple STs and SCCmec elements. Clinical outcome data analysis would 
help understand if the presence or absence of the sesJ gene in a particular ST or SCCmec 
correlates with clinical outcome parameters like polymicrobial infections, persistent 
disease, high CFUs obtained or overall severity of the disease.  
 
Overall, work in this thesis expands our understanding on potential virulence factors 
present in the SCCmec elements in S. epidermidis as well as the MSCRAMM family of 
proteins. Cell wall anchored proteins are critical virulence factors for all Gram-positive 
pathogens. The MSCRAMMs, a family of cell wall anchored proteins, include important 
virulence factors present mostly in Staphylococcus. Based on this work, the 
MSCRAMM family of proteins has expanded from three sub-families to four. It also 
revealed SesJ is the first MSCRAMM present in MGE. Additionally, most S. 
epidermidis studies have been done with isolates from patients with an infected medical 
device. There is considerably less information on clinical S. epidermidis isolates from 
cancer patients. Work in this thesis utilized blood isolates from cancer patients with 
blood stream infections and provided the frequency of previously known and new cell 
wall anchored proteins as well as SCCmec in these isolates. Personalized drugs are the 
new future of medicine. Although personalized medicine has been beneficial in the field 
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of oncology, it has not been expanded to treat difficult bacterial infections. A better 
understanding of S. epidermidis virulence factors and their interactions with specific host 
targets may help create drugs specific to the clinical isolate causing an infection.  
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